"Brand_name","Drug_name_original","Sponsor","Properties","TA","Indication","Indication_EFO","DiseaseId","Year","has_GE","has_GE_ds","Drug_name","DrugId","targetIds"
"Accrufer","Ferric maltol","Shield Therapeutics","Iron replacement product","Other","Iron deficiency anaemia","iron deficiency anemia","HP_0001891",2019,NA,NA,"FERRIC MALTOL","CHEMBL4298110","NA"
"Adakveo","Crizanlizumab","Novartis","P-selectin blocker","Other","Painful complications of SCD","sickle cell disease and related diseases","MONDO_0017146",2019,FALSE,FALSE,"CRIZANLIZUMAB","CHEMBL4297734","ENSG00000174175"
"Adbry","Tralokinumab","LEO Pharma","IL-13-targeted mAb","Other","Atopic dermatitis","atopic eczema","EFO_0000274",2021,TRUE,TRUE,"Tralokinumab","CHEMBL1743081","ENSG00000169194"
"Addyi","Flibanserin","Sprout","Serotonin receptor modulator","Other","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714",2015,FALSE,FALSE,"FLIBANSERIN","CHEMBL231068","ENSG00000178394, ENSG00000102468, ENSG00000069696"
"Adempas","Riociguat","Bayer","Soluble guanylyl cyclase stimulator","Other","Persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361",2013,TRUE,TRUE,"RIOCIGUAT","CHEMBL2107834","ENSG00000123201, ENSG00000164116, ENSG00000061918, ENSG00000152402"
"Adlyxin","Lixisenatide","Sanofi","GLP1 receptor agonist","Other","Diabetes","diabetes mellitus","EFO_0000400",2016,TRUE,TRUE,"LIXISENATIDE","CHEMBL2108336","ENSG00000112164"
"Aduhelm","Aducanumab","Biogen/Eisai","Amyloid-beta-targeted mAb","Other","Alzheimers disease","Alzheimers disease","MONDO_0004975",2021,TRUE,TRUE,"Aducanumab","CHEMBL3039540","ENSG00000142192"
"Aemcolo","Rifamycin","Cosmo Technologies","Ansamycin antibacterial","Other","Travellers diarrhoea","Diarrhea","HP_0002014",2018,NA,NA,"RIFAMYCIN","CHEMBL437765","NA"
"Aimovig","Erenumab","Amgen/Novartis","CGRP receptor antibody","Other","Migraine","migraine disorder","MONDO_0005277",2018,TRUE,TRUE,"ERENUMAB","CHEMBL3833329","ENSG00000064989"
"Ajovy","Fremanezumab","Teva","CGRP antibody","Other","Migraine","migraine disorder","MONDO_0005277",2018,TRUE,TRUE,"FREMANEZUMAB","CHEMBL4297756","ENSG00000110680, ENSG00000175868"
"Aklief","Trifarotene","Galderma","Retinoic acid receptor agonist","Other","Acne vulgaris","acne","EFO_0003894",2019,FALSE,FALSE,"TRIFAROTENE","CHEMBL3707313","ENSG00000172819"
"Akynzeo","Netupitant; palonosetron","Helsinn","An NK1-receptor antagonist plus a 5-HT3-receptor antagonist","Other","Chemotherapy-related nausea","Chemotherapy-induced nausea and vomiting","EFO_0006911",2014,FALSE,FALSE,"NETUPITANT; PALONOSETRON","CHEMBL206253; CHEMBL1189679","ENSG00000115353; ENSG00000166736"
"Akynzeo IV","Palonosetron; fosnetupitant","Helsinn Group","5-HT3-receptor antagonist and NK1-receptor antagonist","Other","Chemotherapy-induced emesis","Chemotherapy-induced nausea and vomiting","EFO_0006911",2018,FALSE,FALSE,"PALONOSETRON; FOSNETUPITANT","CHEMBL1189679; CHEMBL3989917","ENSG00000166736; ENSG00000115353"
"Alecensa","Alectinib","Roche","ALK inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",2015,TRUE,TRUE,"ALECTINIB","CHEMBL1738797","ENSG00000171094, ENSG00000143924, ENSG00000165731"
"Aliqopa","Copanlisib dihydrochloride","Bayer","PI3Kalpha/‚âà√≠¬¨‚Ä¢ inhibitor","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906",2017,TRUE,TRUE,"COPANLISIB","CHEMBL3218576","ENSG00000171608, ENSG00000121879"
"Alunbrig","Brigatinib","Ariad Pharmaceuticals/Takeda","ALK inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",2017,TRUE,TRUE,"BRIGATINIB","CHEMBL3545311","ENSG00000171094, ENSG00000146648"
"Amondys 45","Casimersen","Sarepta","Exon 45-skipping ASO","Other","DMD","Duchenne muscular dystrophy","MONDO_0010679",2021,TRUE,TRUE,"Casimersen","CHEMBL4297566","ENSG00000198947"
"Amvuttra","Vutrisiran","Alnylam","TTR-targeted siRNA","Other","Polyneuropathy of hereditary TTR-mediated amyloidosis","familial amyloid neuropathy","EFO_0004129",2022,TRUE,TRUE,"Vutrisiran","CHEMBL4594511","ENSG00000118271"
"Annovera","Segesterone acetate; ethinyl estradiol","TherapeuticsMD","Progestin and estrogen combined hormonal contraceptive","Other","Female contraception","contraception","EFO_0009520",2018,TRUE,TRUE,"SEGESTERONE ACETATE; ETHINYL ESTRADIOL","CHEMBL3707377; CHEMBL691","ENSG00000082175; ENSG00000091831"
"Anoro Ellipta","Umeclidinium; vilanterol","GSK","Anticholinergic and a LABA","Other","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341",2013,TRUE,TRUE,"UMECLIDINIUM; VILANTEROL","CHEMBL1187833; CHEMBL1198857","ENSG00000133019; ENSG00000169252"
"Anthim","Obiltoxaximab","Elusys Therapeutics","mAb against anthrax toxin","Other","Anthrax","anthrax infection","EFO_0000778",2016,NA,NA,"OBILTOXAXIMAB","CHEMBL3544926","NA"
"Aptiom","Eslicarbazepine","Sunovion","MOA unknown, but thought to involve voltage-gated sodium channels","Other","Partial-onset seizures","Seizure","HP_0001250",2013,TRUE,TRUE,"ESLICARBAZEPINE","CHEMBL315985","ENSG00000168356, ENSG00000169432, ENSG00000144285, ENSG00000007314, ENSG00000136546, ENSG00000185313, ENSG00000136531, ENSG00000183873, ENSG00000196876, ENSG00000153253"
"Aristada","Aripiprazole lauroxil","Alkermes","Extended release atypical antipsychotic","Other","Schizophrenia","schizophrenia","MONDO_0005090",2015,TRUE,TRUE,"ARIPIPRAZOLE LAUROXIL","CHEMBL2219425","ENSG00000102468, ENSG00000178394, ENSG00000149295"
"Artesunate","Artesunate","Amivas","Artemisinin antimalarial","Other","Severe malaria","malaria","EFO_0001068",2020,NA,NA,"ARTESUNATE","CHEMBL361497","NA"
"Asparlas","Calaspargase pegol","Servier","Asparagine specific enzyme","Oncology","ALL","acute lymphoblastic leukemia","EFO_0000220",2018,FALSE,FALSE,"CALASPARGASE PEGOL","CHEMBL2108728","ENSG00000166183"
"Austedo","Deutetrabenazine","Teva","VMAT2 inhibitor","Other","Chorea associated with Huntington disease","chorea; Huntington disease","EFO_0004152; MONDO_0007739",2017,TRUE,TRUE,"DUTETRABENAZINE","CHEMBL3137326","ENSG00000165646"
"Avycaz","Avibactam; ceftazidime","Allergan","A beta-lactamase inhibitor and a cephalosporin","Other","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544",2015,NA,NA,"AVIBACTAM; CEFTAZIDIME","CHEMBL1689063; CHEMBL44354","NA; NA"
"Axumin","Fluciclovine F-18","Blue Earth","Radioactive diagnostic","Other","Suspected prostate cancer recurrence","prostate cancer","MONDO_0008315",2016,TRUE,TRUE,"FLUCICLOVINE F-18","CHEMBL3707267","ENSG00000155465, ENSG00000105281, ENSG00000165349"
"Ayvakit","Avapritinib","Blueprint Medicines","PDGFRA, PDGFRA mutants and KIT kinase inhibitor","Oncology","GIST with PDGFRA exon 18 mutations","gastrointestinal stromal tumor","MONDO_0011719",2020,TRUE,TRUE,"AVAPRITINIB","CHEMBL4204794","ENSG00000157404, ENSG00000134853"
"Azstarys","Dexmethylphenidate; serdexmethylphenidate","Commave Therapeutics","CNS stimulant","Other","ADHD","attention deficit hyperactivity disorder","EFO_0003888",2021,TRUE,TRUE,"Dexmethylphenidate; serdexmethylphenidate","CHEMBL827; CHEMBL4301162","ENSG00000103546, ENSG00000142319; ENSG00000142319, ENSG00000103546"
"Balversa","Erdafitinib","Janssen /J&J","FGFR inhibitor","Oncology","Bladder cancer","urinary bladder carcinoma","MONDO_0004986",2019,TRUE,TRUE,"ERDAFITINIB","CHEMBL3545376","ENSG00000077782, ENSG00000066468, ENSG00000160867, ENSG00000068078"
"Barhemsys","Amisulpride","Acacia","Dopamine receptors D2 & D3 antagonist","Other","Nausea and vomiting after surgery","Nausea and vomiting","HP_0002017",2020,FALSE,FALSE,"AMISULPRIDE","CHEMBL243712","ENSG00000151577, ENSG00000149295, ENSG00000164270, ENSG00000157219, ENSG00000158748, ENSG00000166736, ENSG00000186090, ENSG00000178084, ENSG00000102468, ENSG00000149305, ENSG00000179097, ENSG00000135914, ENSG00000178394, ENSG00000168830, ENSG00000147246, ENSG00000186038, ENSG00000148680, ENSG00000135312, ENSG00000179546"
"Bavencio","Avelumab","Merck KGaA/Pfizer","PDL1-blocking antibody","Oncology","Merkel cell carcinoma","Merkel cell skin cancer","EFO_1001471",2017,TRUE,TRUE,"AVELUMAB","CHEMBL3833373","ENSG00000120217"
"Baxdela","Delafloxacin","Melinta Therapeutics","Fluoroquinolone antibacterial","Other","Acute bacterial skin and skin structure infections","staphylococcal skin infections","EFO_1001849",2017,NA,NA,"DELAFLOXACIN","CHEMBL2105637","NA"
"Beleodaq","Belinostat","Spectrum","Histone-deacetylase inhibitor","Other","Peripheral T-cell lymphoma","unspecified peripheral T-cell lymphoma","EFO_0000211",2014,TRUE,FALSE,"BELINOSTAT","CHEMBL408513","ENSG00000108840, ENSG00000147099, ENSG00000061273, ENSG00000068024, ENSG00000171720, ENSG00000094631, ENSG00000163517, ENSG00000048052, ENSG00000100429, ENSG00000196591, ENSG00000116478"
"Belsomra","Suvorexant","Merck & Co.","Orexin-receptor antagonist","Other","Insomnia","insomnia","EFO_0004698",2014,TRUE,TRUE,"SUVOREXANT","CHEMBL1083659","ENSG00000137252, ENSG00000121764"
"Benznidazole","Benznidazole","Chemo Research","Nitroimidazole antimicrobial","Other","Chagas disease","Chagas disease","MONDO_0001444",2017,NA,NA,"BENZNIDAZOLE","CHEMBL110","NA"
"Beovu","Brolucizumab","Novartis","VEGF inhibitor","Other","Wet age-related macular degeneration","macular degeneration","EFO_0009606",2019,TRUE,TRUE,"BROLUCIZUMAB","CHEMBL3707357","ENSG00000112715"
"Besponsa","Inotuzumab ozogamicin","Pfizer","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö¬®drug conjugate","Oncology","B cell precursor ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511",2017,TRUE,TRUE,"INOTUZUMAB OZOGAMICIN","CHEMBL2108611","ENSG00000012124"
"Besremi","Ropeginterferon alfa-2b","Pharmaessentia","PEGylated interferon alpha-2b","Oncology","Polycythaemia vera","polycythemia vera","EFO_0002429",2021,TRUE,TRUE,"Ropeginterferon alfa-2b","CHEMBL4297819","ENSG00000142166, ENSG00000159110"
"Bevyxxa","Betrixaban","Portola Pharmaceuticals","FXa inhibitor","Other","Prophylaxis of venous thromboembolism","venous thromboembolism","EFO_0004286",2017,TRUE,TRUE,"BETRIXABAN","CHEMBL512351","ENSG00000126218"
"Biktarvy","Bictegravir; emtricitabine; tenofovir alafenamide","Gilead Sciences","HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors","Other","HIV","hiv infection","EFO_0000764",2018,NA,NA,"BICTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE","CHEMBL3989866; CHEMBL885; CHEMBL2107825","NA; NA; NA"
"Blenrep","Belantamab mafodotin","GlaxoSmithKline","BCMA-directed ADC, with microtubule inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2020,TRUE,TRUE,"BELANTAMAB MAFODOTIN","CHEMBL4298209","ENSG00000048462, ENSG00000152086, ENSG00000167553, ENSG00000188229, ENSG00000137267, ENSG00000176014, ENSG00000261456, ENSG00000127824, ENSG00000123416, ENSG00000137285, ENSG00000258947, ENSG00000167552, ENSG00000198033, ENSG00000196230, ENSG00000104833, ENSG00000101162"
"Blincyto","Blinatumomab","Amgen","CD19- and CD3-bispecific antibody","Oncology","B-ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511",2014,TRUE,TRUE,"BLINATUMOMAB","CHEMBL1742992","ENSG00000177455, ENSG00000160654, ENSG00000167286, ENSG00000198851"
"Braftovi","Encorafenib","Array BioPharma","BRAF inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756",2018,TRUE,TRUE,"ENCORAFENIB","CHEMBL3301612","ENSG00000157764"
"Breo Ellipta","Fluticasone; vilanterol","GSK","Corticosteroid plus LABA","Other","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341",2013,TRUE,TRUE,"FLUTICASONE; VILANTEROL","CHEMBL1473; CHEMBL1198857","ENSG00000113580; ENSG00000169252"
"Brexafemme","Ibrexafungerp","Scynexis","Triterpenoid antifungal","Other","Vulvovaginal candidiasis",NA,NA,2021,NA,NA,"Ibrexafungerp","CHEMBL4297513","NA"
"Bridion","Sugammadex","Merck & Co.","A modified gamma cyclodextrin","Other","Reversal of neuromuscular blockade during surgery","neuromuscular disease","EFO_1001902",2015,NA,NA,"SUGAMMADEX","CHEMBL2111107","NA"
"Brineura","Cerliponase alfa","BioMarin Pharmaceutical","Tripeptidyl peptidase","Other","Tripeptidyl peptidase 1 deficiency (neuronal ceroid lipofuscinosis type 2*)","neuronal ceroid lipofuscinosis 2","MONDO_0008769",2017,TRUE,TRUE,"CERLIPONASE ALFA","CHEMBL3544921","ENSG00000166340"
"Brintellix","Vortioxetine","Takeda","Serotonin reuptake inhibitor","Other","Major depressive disorder","major depressive disorder","MONDO_0002009",2013,TRUE,TRUE,"VORTIOXETINE","CHEMBL2104993","ENSG00000178394, ENSG00000108576, ENSG00000166736"
"Briumvi","Ublituximab","TG Therapeutics","CD20-targeted mAb","Other","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929",2022,FALSE,FALSE,"Ublituximab","CHEMBL2108354","ENSG00000156738"
"Briviact","Brivaracetam","UCB","Anticonvulsant with unknown MOA, binds to SV2A","Other","Partial-onset seizures","Focal-onset seizure","HP_0007359",2016,TRUE,TRUE,"BRIVARACETAM","CHEMBL607400","ENSG00000159164, ENSG00000144285"
"Brukinsa","Zanubrutinib","BeiGene","BTK inhibitor","Oncology","Mantle cell lymphoma","mantle cell lymphoma","EFO_1001469",2019,TRUE,TRUE,"ZANUBRUTINIB","CHEMBL3936761","ENSG00000010671"
"Byfavo","Remimazolam","Acacia","Benzodiazepine","Other","Procedural sedation","sedation","EFO_0009868",2020,TRUE,TRUE,"REMIMAZOLAM","CHEMBL4297526","ENSG00000102287, ENSG00000163288, ENSG00000186297, ENSG00000145864, ENSG00000113327, ENSG00000011677, ENSG00000094755, ENSG00000163285, ENSG00000151834, ENSG00000109158, ENSG00000268089, ENSG00000187730, ENSG00000182256, ENSG00000022355, ENSG00000145863, ENSG00000166206"
"Bylvay","Odevixibat","Albireo","IBAT inhibitor","Other","Pruritus in PFIC","familial intrahepatic cholestasis","MONDO_0017290",2021,TRUE,TRUE,"Odevixibat","CHEMBL4297588","ENSG00000125255"
"Cabenuva Kit","Cabotegravir; rilpivirine","ViiV","INSTI and an NNRTI","Other","HIV-1 infection",NA,NA,2021,NA,NA,"Cabotegravir; rilpivirine","CHEMBL2403238; CHEMBL175691","NA; NA"
"Cablivi","Caplacizumab","Sanofi/Ablynx","vWF-directed nanobody","Other","ATTP","thrombotic thrombocytopenic purpura","MONDO_0018896",2019,TRUE,TRUE,"CAPLACIZUMAB","CHEMBL2109624","ENSG00000110799"
"Calquence","Acalabrutinib","AstraZeneca/Acerta Pharma","BTK inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469",2017,TRUE,TRUE,"ACALABRUTINIB","CHEMBL3707348","ENSG00000010671"
"Camzyos","Mavacamten","Bristol Myers Squibb","Cardiac myosin inhibitor","Other","Classes of obstructive HCM (Hypertrophic Obstructive Cardiomyopathy)","hypertrophic cardiomyopathy","EFO_0000538",2022,TRUE,TRUE,"Mavacamten","CHEMBL4297517","ENSG00000092054"
"Caplyta","Lumateperone","Intra-Cellular Therapies","Atypical antipsychotic","Other","Schizophrenia","schizophrenia","MONDO_0005090",2019,TRUE,TRUE,"LUMATEPERONE","CHEMBL3306803","ENSG00000102468, ENSG00000108576, ENSG00000149295"
"Cerdelga","Eliglustat","Genzyme","Glucosylceramide-synthase inhibitor","Other","Gaucher's disease","Gaucher disease","MONDO_0018150",2014,FALSE,FALSE,"ELIGLUSTAT","CHEMBL2110588","ENSG00000148154"
"Cholbam","Cholic acid","Retrophin","A primary bile acid","Other","Bile acid synthesis disorders and peroxisomal disorders","peroxisomal disease; Disorder of bile acid synthesis","MONDO_0019053; Orphanet_79168",2015,NA,NA,"CHOLIC ACID","CHEMBL205596","NA"
"Cibinqo","Abrocitinib","Pfizer","JAK inhibitor","Other","Atopic dermatitis","atopic eczema, Eczema","EFO_0000274; HP_0000964",2022,TRUE,TRUE,"Abrocitinib","CHEMBL3655081","ENSG00000162434"
"Cinqair","Reslizumab","Teva","IL-5 antagonist","Other","Severe asthma","Status Asthmaticus","EFO_0008590",2016,TRUE,TRUE,"RESLIZUMAB","CHEMBL2107884","ENSG00000113525"
"Copiktra","Duvelisib","Verastem","PI3K inhibitor","Oncology","CLL, FL and SLL","chronic lymphocytic leukemia; follicular lymphoma","EFO_0000095; MONDO_0018906",2018,TRUE,TRUE,"DUVELISIB","CHEMBL3039502","ENSG00000105851, ENSG00000171608"
"Copper dotatate Cu-64","Copper dotatate Cu-64","Radiomedix","Radioactive diagnostic","Other","Imaging, cancer","neuroendocrine neoplasm","EFO_1001901",2020,TRUE,FALSE,"COPPER DOTATATE CU-64","CHEMBL4297339","ENSG00000180616"
"Corlanor","Ivabradine","Amgen","Hyperpolarization-activated cyclic nucleotide-gated channel blocker","Other","Chronic heart failure","congestive heart failure","EFO_0000373",2015,TRUE,TRUE,"IVABRADINE","CHEMBL471737","ENSG00000138622"
"Cosela","Trilaciclib","G1 Therapeutics","CDK4 and CDK6 kinase inhibitor","Oncology","Chemotherapy-induced myelosuppression","myelosuppression; small cell lung carcinoma","EFO_0007053; EFO_0000702",2021,TRUE,TRUE,"Trilaciclib","CHEMBL3894860","ENSG00000135446, ENSG00000105810"
"Cosentyx","Secukinumab","Novartis","IL-17A antagonist","Other","Plaque psoriasis, *psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.","psoriasis vulgaris","EFO_1001494",2015,FALSE,FALSE,"SECUKINUMAB","CHEMBL1743068","ENSG00000112115"
"Cotellic","Cobimetinib","Genentech","MEK inhibitor","Oncology","Melanoma with BRAFV600E/K mutations","melanoma","EFO_0000756",2015,TRUE,TRUE,"COBIMETINIB","CHEMBL2146883","ENSG00000126934, ENSG00000169032"
"Cresemba","Isavuconazonium","Astellas","Azole antifungal","Other","Antifungal","aspergillosis; mucormycosis","EFO_0007157; EFO_0007380",2015,NA,NA,"ISAVUCONAZONIUM","CHEMBL1183349","NA"
"Crysvita","Burosumab","Ultragenyx Pharmaceutical/Kyowa Hakko Kirin","FGF23 antibody","Other","X-linked hypophosphataemia","Hypophosphatemia","HP_0002148",2018,TRUE,TRUE,"BUROSUMAB","CHEMBL3707326","ENSG00000118972"
"Cyramza","Ramucirumab","Eli Lilly","VEGFR2 antagonist","Oncology","Gastric cancer","gastric cancer","MONDO_0001056",2014,TRUE,TRUE,"RAMUCIRUMAB","CHEMBL1743062","ENSG00000128052"
"Cytalux","Pafolacianine","On Target Labs","Fluorescent FR imaging agent","Other","Ovarian cancer imaging","ovarian carcinoma","EFO_0001075",2021,FALSE,FALSE,"Pafolacianine","CHEMBL4297412","ENSG00000110195"
"Daklinza","Daclatasvir","Bristol-Myers Squibb","NS5A inhibitor","Other","HCV","hepatitis C virus infection","EFO_0003047",2015,NA,NA,"DACLATASVIR","CHEMBL2023898","NA"
"Dalvance","Dalbavancin","Durata","Semisynthetic lipoglycopeptide","Other","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849",2014,NA,NA,"DALBAVANCIN","CHEMBL3301669","NA"
"Danyelza","Naxitamab","Y-mAbs Therapeutics","GD2-directed mAb","Oncology","High-risk neuroblastoma","neuroblastoma","EFO_0000621",2020,NA,NA,"NAXITAMAB","CHEMBL4297984","NA"
"Darzalex","Daratumumab","Johnson & Johnson","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2015,TRUE,TRUE,"DARATUMUMAB","CHEMBL1743007","ENSG00000004468"
"Daurismo","Glasdegib","Pfizer","Hedgehog pathway inhibitor","Oncology","AML",NA,"EFO_0000222",2018,TRUE,TRUE,"GLASDEGIB","CHEMBL2043437","ENSG00000128602"
"Daxxify","DaxibotulinumtoxinA","Revance","Botulinum toxin","Other","Glabellar lines","Facial wrinkling","HP_0009762",2022,FALSE,FALSE,"DaxibotulinumtoxinA","CHEMBL3707359","ENSG00000132639"
"Dayvigo","Lemborexant","Eisai","Orexin receptor antagonist","Other","Insomnia","insomnia","EFO_0004698",2019,TRUE,TRUE,"LEMBOREXANT","CHEMBL3545367","ENSG00000121764, ENSG00000137252"
"Defitelio","Defibrotide sodium","Gentium","Profibrinolytic","Other","Hepatic veno-occlusive disease","hepatic veno-occlusive disease","MONDO_0019514",2016,TRUE,TRUE,"DEFIBROTIDE SODIUM","CHEMBL3707226","ENSG00000122194"
"Diacomit","Stiripentol","Biocodex","GABA reuptake inhibitor","Other","Dravet syndrome","dravet syndrome","Orphanet_33069",2018,TRUE,TRUE,"STIRIPENTOL","CHEMBL1983350","ENSG00000022355"
"Dojolvi","Triheptanoin","Ultragenyx","Medium-chain triglyceride","Other","LC-FAODs","inherited fatty acid metabolism disorder","MONDO_0037858",2020,NA,NA,"TRIHEPTANOIN","CHEMBL4297585","NA"
"Doptelet","Avatrombopag","Dova Pharmaceuticals","Thrombopoietin receptor agonist","Other","Thrombocytopenia","thrombocytopenia","HP_0001873",2018,TRUE,TRUE,"AVATROMBOPAG","CHEMBL2103883","ENSG00000117400"
"Dotarem","Gadoterate meglumine","Guerbet","Gadolinium-based contrast agent","Other","Contrast agent to visualize disruption of the blood-brain barrier",NA,NA,2013,NA,NA,"GADOTERATE MEGLUMINE","CHEMBL2219415","NA"
"Duavee","Bazedoxifene acetate; oestrogens","Pfizer","Conjugated oestrogens with an oestrogen receptor modulator","Other","Moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis","menopause; postmenopausal osteoporosis","EFO_0003922; EFO_0003854",2013,TRUE,TRUE,"BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","CHEMBL2106615; CHEMBL1201649","ENSG00000091831, ENSG00000140009; ENSG00000140009, ENSG00000091831"
"Dupixent","Dupilumab","Regeneron/Sanofi","IL-4Ralpha antagonist","Other","Atopic dermatitis","atopic eczema","EFO_0000274",2017,TRUE,TRUE,"DUPILUMAB","CHEMBL2108675","ENSG00000077238"
"Ebanga","Ansuvimab","Ridgeback","Ebola glycoprotein-directed mAb","Other","Ebola virus","Ebola hemorrhagic fever","EFO_0007243",2020,NA,NA,"ANSUVIMAB","CHEMBL4594388","NA"
"Egaten","Triclabendazole","Novartis","Anthelmintic","Other","Fascioliasis","fascioliasis","EFO_1001324",2019,NA,NA,"TRICLABENDAZOLE","CHEMBL1086440","NA"
"Elahere","Mirvetuximab soravtansine","ImmunoGen","FR_-targeted antibody-drug conjugate","Oncology","Ovarian cancer","ovarian carcinoma","EFO_0001075",2022,TRUE,TRUE,"Mirvetuximab soravtansine","CHEMBL3545132","ENSG00000110195, ENSG00000127824, ENSG00000152086, ENSG00000261456, ENSG00000101162, ENSG00000188229, ENSG00000104833, ENSG00000258947, ENSG00000123416, ENSG00000198033, ENSG00000167553, ENSG00000137285, ENSG00000167552, ENSG00000176014, ENSG00000137267, ENSG00000196230"
"Elucirem","Gadopiclenol","Guerbet","Gadolinium-based contrast agent","Other","Lesions with abnormal vascularity",NA,NA,2022,NA,NA,"Gadopiclenol","CHEMBL4297634","NA"
"Elzonris","Tagraxofusp","Stemline Therapeutics","IL-3 and diphtheria toxin fusion protein","Oncology","Blastic plasmacytoid dendritic cell neoplasm","blastic plasmacytoid dendritic cell neoplasm","EFO_0010580",2018,FALSE,FALSE,"TAGRAXOFUSP","CHEMBL4297573","ENSG00000167658, ENSG00000185291"
"Emflaza","Deflazacort","PTC Therapeutics","Corticosteroid","Other","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679",2017,FALSE,FALSE,"DEFLAZACORT","CHEMBL1201891","ENSG00000113580"
"Emgality","Galcanezumab","Eli Lilly","CGRP antibody","Other","Migraine","migraine disorder","MONDO_0005277",2018,TRUE,TRUE,"GALCANEZUMAB","CHEMBL3707328","ENSG00000175868, ENSG00000110680"
"Empaveli","Pegcetacoplan","Apellis","Complement protein C3 inhibitor","Other","PNH","paroxysmal nocturnal hemoglobinuria","MONDO_0100244",2021,TRUE,TRUE,"Pegcetacoplan","CHEMBL4298211","ENSG00000125730"
"Empliciti","Elotuzumab","Bristol-Myers Squibb","SLAMF7-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2015,TRUE,TRUE,"ELOTUZUMAB","CHEMBL1743010","ENSG00000026751"
"Enhertu","Trastuzumab deruxtecan","Daiichi Sankyo/AstraZeneca","HER2-directed ADC","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",2019,TRUE,TRUE,"TRASTUZUMAB DERUXTECAN","CHEMBL4297844","ENSG00000141736, ENSG00000198900"
"Enjaymo","Sutimlimab","Bioverativ","C1s-targeted mAb","Other","RBC transfusion due to haemolysis in CAD (cold agglutinin disease)","Anemia, Hemolytic, Autoimmune","EFO_1001264",2022,FALSE,FALSE,"Sutimlimab","CHEMBL4297832","ENSG00000182326"
"Enspryng","Satralizumab","Roche/Genentech","IL-6R-directed mAb","Other","NMOSD","neuromyelitis optica","EFO_0004256",2020,TRUE,TRUE,"SATRALIZUMAB","CHEMBL3833307","ENSG00000160712, ENSG00000134352"
"Entresto","Sacubitril; valsartan","Novartis","A neprilysin inhibitor plus an angiotensin II receptor blocker","Other","Chronic heart failure","congestive heart failure","EFO_0000373",2015,TRUE,TRUE,"SACUBITRIL; VALSARTAN","CHEMBL3137301; CHEMBL1069","ENSG00000196549; ENSG00000144891"
"Entyvio","Vedolizumab","Takeda","Integrin-receptor antagonist","Other","Ulcerative colitis and Crohn's disease","ulcerative colitis; Crohn's disease","EFO_0000729; EFO_0000384",2014,TRUE,TRUE,"VEDOLIZUMAB","CHEMBL1743087","ENSG00000115232, ENSG00000139626"
"Epclusa","Sofosbuvir; velpatasvir","Gilead Sciences","A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor","Other","genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)","hepatitis C virus infection","EFO_0003047",2016,NA,NA,"SOFOSBUVIR; VELPATASVIR","CHEMBL1259059; CHEMBL3545062","NA; NA"
"Epidiolex","Cannabidiol","GW Pharmaceuticals","Cannabinoid","Other","Dravet syndrome and Lennox-Gastaut syndrome","Dravet syndrome; Lennox-Gastaut syndrome","Orphanet_33069; MONDO_0016532",2018,TRUE,TRUE,"CANNABIDIOL","CHEMBL190461","ENSG00000118432"
"Erleada","Apalutamide","Johnson & Johnson","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315",2018,TRUE,TRUE,"APALUTAMIDE","CHEMBL3183409","ENSG00000169083"
"Esbriet","Pirfenidone","InterMune","MOA unknown","Other","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768",2014,NA,NA,"PIRFENIDONE","CHEMBL1256391","NA"
"Eucrisa","Crisaborole","Pfizer/Anacor Pharmaceuticals","PDE4 inhibitor","Other","Atopic dermatitis","atopic eczema","EFO_0000274",2016,TRUE,TRUE,"CRISABOROLE","CHEMBL484785","ENSG00000184588, ENSG00000113448, ENSG00000065989, ENSG00000105650"
"Evenity","Romosozumab","Amgen","Sclerostin inhibitor","Other","Osteoporosis","osteoporosis","EFO_0003882",2019,TRUE,TRUE,"ROMOSOZUMAB","CHEMBL2107874","ENSG00000167941"
"Evkeeza","Evinacumab","Regeneron","ANGPTL3-targeted mAb","Other","HoFH","homozygous familial hypercholesterolemia","MONDO_0018328",2021,TRUE,TRUE,"Evinacumab","CHEMBL3545191","ENSG00000132855"
"Evrysdi","Risdiplam","Roche/Genentech","SMN2 splicing modifier","Other","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525",2020,TRUE,TRUE,"RISDIPLAM","CHEMBL4297528","ENSG00000205571"
"ExEm Foam","Air polymer-type A","Giskit","Ultrasound contrast agent","Other","Assess fallopian tube patency in women with known or suspected infertility","infertility","EFO_0000545",2019,NA,NA,"AIR POLYMER-TYPE A","CHEMBL4594264","NA"
"Exkivity","Mobocertinib","Takeda","EGFR kinase inhibitor","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",2021,TRUE,TRUE,"Mobocertinib","CHEMBL4650319","ENSG00000146648"
"Exondys 51","Eteplirsen","Sarepta Therapeutics","ASO designed to target dystrophin pre-mRNA","Other","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679",2016,TRUE,TRUE,"ETEPLIRSEN","CHEMBL2108278","ENSG00000198947"
"Farxiga","Dapagliflozin","AstraZeneca","SGLT2 inhibitor","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2014,TRUE,TRUE,"DAPAGLIFLOZIN","CHEMBL429910","ENSG00000140675"
"Farydak","Panobinostat","Novartis","Histone deacetylase inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2015,TRUE,TRUE,"PANOBINOSTAT","CHEMBL483254","ENSG00000100429, ENSG00000196591, ENSG00000163517, ENSG00000061273, ENSG00000068024, ENSG00000048052, ENSG00000116478, ENSG00000108840, ENSG00000094631, ENSG00000171720, ENSG00000147099"
"Fasenra","Benralizumab","AstraZeneca","IL-5Ralpha-directed monoclonal antibody","Other","Severe asthma","Status Asthmaticus","EFO_0008590",2017,FALSE,FALSE,"BENRALIZUMAB","CHEMBL1742991","ENSG00000091181"
"Fetroja","Cefiderocol","Shionogi","Cephalosporin antibacterial","Other","Complicated urinary tract infections","urinary tract infection","EFO_0003103",2019,NA,NA,"CEFIDEROCOL","CHEMBL3989974","NA"
"Fexinidazole","Fexinidazole","Sanofi/DNDi","Nitroimidazole antimicrobial","Other","Sleeping sickness",NA,NA,2021,NA,NA,"Fexinidazole","CHEMBL1631694","NA"
"Firdapse","Amifampridine","Catalyst Pharmaceuticals","Potassium channel blocker","Other","Lambert-Eaton myasthenic syndrome","Lambert-Eaton myasthenic syndrome","Orphanet_43393",2018,FALSE,FALSE,"AMIFAMPRIDINE","CHEMBL354077","ENSG00000130037, ENSG00000182255, ENSG00000173826, ENSG00000111262, ENSG00000178342, ENSG00000131398, ENSG00000140015, ENSG00000055118, ENSG00000168418, ENSG00000143473, ENSG00000183960, ENSG00000151079, ENSG00000184408, ENSG00000116396, ENSG00000171126, ENSG00000168263, ENSG00000026559, ENSG00000170745, ENSG00000185760, ENSG00000135519, ENSG00000184156, ENSG00000075043, ENSG00000117013, ENSG00000158445, ENSG00000166006, ENSG00000129159, ENSG00000124134, ENSG00000156486, ENSG00000143105, ENSG00000182674, ENSG00000053918, ENSG00000089558, ENSG00000177301, ENSG00000162975, ENSG00000102057, ENSG00000184611, ENSG00000171385, ENSG00000177272, ENSG00000104848, ENSG00000164794"
"Flortaucipir F-18","Flortaucipir F-18","Eli Lilly","Radioactive diagnostic","Other","Imaging, tau in Alzheimer disease","Alzheimer disease","MONDO_0004975",2020,TRUE,TRUE,"FLORTAUCIPIR F-18","CHEMBL3545253","ENSG00000186868"
"Fluorodopa F-18","Fluorodopa F-18","Feinstein Institutes","Radioactive diagnostic","Other","Diagnosis of parkinsonian syndromes","Parkinson disease","MONDO_0005180",2019,NA,NA,"FLUORODOPA F-18","CHEMBL3400972","NA"
"Fluoroestradiol F-18","Fluoroestradiol F-18","Zionexa","Radioactive diagnostic","Other","Imaging, breast cancer","breast carcinoma","EFO_0000305",2020,TRUE,TRUE,"FLUOROESTRADIOL F-18","CHEMBL4594261","ENSG00000186868"
"Fotivda","Tivozanib","Aveo","VEGFR kinase inhibitor","Oncology","Renal cell carcinoma","renal cell carcinoma","EFO_0000681",2021,TRUE,TRUE,"Tivozanib","CHEMBL1289494","ENSG00000102755, ENSG00000128052, ENSG00000037280, ENSG00000157404, ENSG00000113721"
"Galafold","Migalastat","Amicus Therapeutics","beta-galactosidase regulator","Other","Fabry disease","fabry disease","MONDO_0010526",2018,TRUE,TRUE,"MIGALASTAT","CHEMBL110458","ENSG00000102393"
"Gallium dotatoc Ga-68","Gallium dotatoc Ga-68","UIHC PET Imaging Center","Radioactive diagnostic","Other","Localization of somatostatin receptor-positive neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901",2019,TRUE,FALSE,"GALLIUM DOTATOC GA-68","CHEMBL4297340","ENSG00000180616"
"Gamifant","Emapalumab","Novimmune","Interferon-‚âà√≠‚Äö√¢‚Ä¢-blocking antibody","Other","Primary haemophagocytic lymphohistiocytosis","genetic hemophagocytic lymphohistiocytosis","MONDO_0015541",2018,TRUE,TRUE,"EMAPALUMAB","CHEMBL3989977","ENSG00000111537"
"Gavreto","Pralsetinib","Blueprint Medicines/Roche","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",2020,TRUE,TRUE,"PRALSETINIB","CHEMBL4582651","ENSG00000170759, ENSG00000165731, ENSG00000108091"
"Gazyva","Obinutuzumab","Genentech","Humanized CD20-specific monoclonal antibody","Oncology","Previously untreated chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095",2013,TRUE,TRUE,"OBINUTUZUMAB","CHEMBL1743048","ENSG00000156738"
"Gemtesa","Vibegron","Urovant Sciences","Beta-3 adrenergic receptor agonist","Other","Overactive bladder","overactive bladder","EFO_1000781",2020,FALSE,FALSE,"VIBEGRON","CHEMBL2107826","ENSG00000188778"
"Genvoya","Elvitegravir; cobicistat; emtricitabine; tenofovir","Gilead","An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors","Other","HIV","HIV infection","EFO_0000764",2015,NA,FALSE,"ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR","CHEMBL204656; CHEMBL2095208; CHEMBL885; CHEMBL483","NA; ENSG00000160870, ENSG00000106258, ENSG00000160868, ENSG00000021461; NA; NA"
"Giapreza","Angiotensin II","La Jolla Pharmaceutical Company","Synthetic human angiotensin","Other","Blood pressure in adults with septic or other distributive shock","septic shock; blood pressure","EFO_0006834; EFO_0004325",2017,TRUE,TRUE,"ANGIOTENSIN II","CHEMBL408403","ENSG00000144891"
"Gilotrif","Afatinib","Boehringer Ingelheim","EGFR (ERBB1), HER2 (ERBB2), and HER4 (ERRB4) kinase inhibitor","Oncology","First-line treatment of patients with metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test","non-small cell lung carcinoma","EFO_0003060",2013,TRUE,TRUE,"AFATINIB","CHEMBL1173655","ENSG00000141736, ENSG00000146648, ENSG00000178568"
"Givlaari","Givosiran","Alnylam","ALAS1-directed siRNA","Other","Acute hepatic porphyria","acute hepatic porphyria","Orphanet_95157",2019,FALSE,FALSE,"GIVOSIRAN","CHEMBL4297760","ENSG00000023330"
"Harvoni","Ledipasvir; sofosbuvir","Gilead Sciences","An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor","Other","Genotype 1 HCV","hepatitis C virus infection","EFO_0003047",2014,NA,NA,"LEDIPASVIR; SOFOSBUVIR","CHEMBL2374220; CHEMBL1259059","NA; NA"
"Hemlibra","Emicizumab","Roche/Genentech","Bispecific FIX and FX-directed antibody","Other","Haemophilia A","hemophilia A","MONDO_0010602",2017,TRUE,TRUE,"EMICIZUMAB","CHEMBL3833393","ENSG00000126218, ENSG00000101981"
"Hetlioz","Tasimelteon","Vanda","Melatonin-receptor agonist","Other","Non-24-hour sleep-wake disorder","sleep-wake disorder","MONDO_0003406",2014,TRUE,TRUE,"TASIMELTEON","CHEMBL2103822","ENSG00000134640, ENSG00000168412"
"Ibrance","Palbociclib","Pfizer","CDK4 and CDK6 inhibitor","Oncology","ER-positive, HER2-negative advanced breast cancer","HER2 negative breast carcinoma","EFO_0009780",2015,TRUE,TRUE,"PALBOCICLIB","CHEMBL189963","ENSG00000135446, ENSG00000110092, ENSG00000105810"
"Ibsrela","Tenapanor","Ardelyx","NHE3 inhibitor","Other","IBS with constipation","irritable bowel syndrome","EFO_0000555",2019,FALSE,FALSE,"TENAPANOR","CHEMBL3304485","ENSG00000066230"
"Idhifa","Enasidenib mesylate","Celgene/Agios","IDH2 inhibitor","Oncology","IDH2-mutated AML","acute myeloid leukemia","EFO_0000222",2017,TRUE,TRUE,"ENASIDENIB MESYLATE","CHEMBL3989931","ENSG00000182054"
"Ilumya","Tildrakizumab","Sun Pharma","IL-23 antibody","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2018,TRUE,TRUE,"TILDRAKIZUMAB","CHEMBL2108681","ENSG00000110944, ENSG00000113302"
"Imbruvica","Ibrutinib","Pharmacyclics","Bruton's tyrosine kinase inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469",2013,TRUE,TRUE,"IBRUTINIB","CHEMBL1873475","ENSG00000010671"
"Imcivree","Setmelanotide","Rhythm","Melanocortin receptor 4 agonist","Other","Rare genetic diseases of obesity","Bardet-Biedl syndrome","MONDO_0015229",2020,TRUE,TRUE,"SETMELANOTIDE","CHEMBL3301624","ENSG00000166603"
"Imfinzi","Durvalumab","AstraZeneca","PDL1-blocking antibody","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528",2017,TRUE,TRUE,"DURVALUMAB","CHEMBL3301587","ENSG00000120217"
"Imjudo","Tremelimumab","AstraZeneca","CTLA4-targeted mAb","Oncology","Hepatocellular carcinoma","hepatocellular carcinoma","EFO_0000182",2022,TRUE,TRUE,"Tremelimumab","CHEMBL2108658","ENSG00000163599"
"Impavido","Miltefosine","Knight","MOA unknown","Other","Leishmaniasis","Leishmaniasis","EFO_0005044",2014,NA,NA,"MILTEFOSINE","CHEMBL125","NA"
"Ingrezza","Valbenazine","Neurocrine Biosciences","VMAT2 inhibitor","Other","Tardive dyskinesia","movement disorder","EFO_0004280",2017,TRUE,TRUE,"VALBENAZINE","CHEMBL2364639","ENSG00000165646"
"Inmazeb","Atoltivimab; odesivimab; maftivimab","Regeneron","Cocktail of Ebola glycoprotein-directed mAbs","Other","Ebola virus","Ebola hemorrhagic fever","EFO_0007243",2020,NA,NA,"ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB","CHEMBL4298183; CHEMBL4298188; CHEMBL4298184","NA; NA; NA"
"Inqovi","Cedazuridine; decitabine","Otsuka","Cytidine deaminase inhibitor; nucleoside metabolic inhibitor","Other","Myelodysplastic syndromes","myelodysplastic syndrome","EFO_0000198",2020,TRUE,TRUE,"CEDAZURIDINE; DECITABINE","CHEMBL3237547; CHEMBL1201129","ENSG00000158825; ENSG00000119772, ENSG00000130816"
"Inrebic","Fedratinib","Celgene/BMS","JAK2 and FLT3 inhibitor","Other","Myelofibrosis","myelofibrosis","MONDO_0044903",2019,TRUE,TRUE,"FEDRATINIB","CHEMBL1287853","ENSG00000096968, ENSG00000122025"
"Invokana","Canagliflozin","Janssen","SGLT2 inhibitor","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2013,TRUE,TRUE,"CANAGLIFLOZIN; CANAGLIFLOZIN","CHEMBL4594217; CHEMBL2048484","ENSG00000140675; ENSG00000140675"
"Isturisa","Osilodrostat","Recordati Rare Diseases","Cortisol synthesis inhibitor","Other","Cushing disease","Cushing syndrome","EFO_0003099",2020,TRUE,TRUE,"OSILODROSTAT","CHEMBL3099695","ENSG00000160882"
"Jardiance","Empagliflozin","Boehringer Ingelheim","SGLT2 inhibitor","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2014,TRUE,TRUE,"EMPAGLIFLOZIN","CHEMBL2107830","ENSG00000140675"
"Jemperli","Dostarlimab","GlaxoSmithKline","PD1-targeted mAb","Oncology","Endometrial cancer","endometrial cancer","MONDO_0011962",2021,TRUE,TRUE,"Dostarlimab","CHEMBL4298124","ENSG00000188389"
"Jeuveau","Prabotulinumtoxin A","Evolus","Acetylcholine release inhibitor and a neuromuscular blocking agent","Other","Glabellar lines associated with corrugator and/or procerus muscle activity","Facial wrinkling","HP_0009762",2019,FALSE,FALSE,"PRABOTULINUMTOXIN A","CHEMBL4297229","ENSG00000132639"
"Jublia","Efinaconazole","Dow","Azole antifungal","Other","Onychomycosis of the toenails","paronychia","EFO_0007421",2014,NA,NA,"EFINACONAZOLE","CHEMBL2103877","NA"
"Kadcyla","Ado-trastuzumab emtansine","Genentech","HER2-targeted antibody and microtubule inhibitor conjugate","Oncology","HER2-positive metastatic breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",2013,TRUE,TRUE,"TRASTUZUMAB EMTANSINE","CHEMBL1743082","ENSG00000167553, ENSG00000196230, ENSG00000137285, ENSG00000123416, ENSG00000176014, ENSG00000137267, ENSG00000101162, ENSG00000258947, ENSG00000261456, ENSG00000188229, ENSG00000104833, ENSG00000127824, ENSG00000198033, ENSG00000167552, ENSG00000152086, ENSG00000141736"
"Kanuma","Sebelipase alfa","Alexion","Enzyme replacement therapy","Other","LAL deficiency","lysosomal acid lipase deficiency","MONDO_0010204",2015,TRUE,TRUE,"SEBELIPASE ALFA","CHEMBL3039537","ENSG00000107798"
"Kengreal","Cangrelor","Medicines Company","P2Y12 platelet inhibitor","Other","Myocardial infarction, repeat coronary revascularization, and stent thrombosis","myocardial infarction","EFO_0000612",2015,FALSE,FALSE,"CANGRELOR","CHEMBL334966","ENSG00000169313"
"Kerendia","Finerenone","Bayer","Non-steroidal MR antagonist","Other","CKD with type 2 diabetes","chronic kidney disease","EFO_0003884",2021,TRUE,TRUE,"Finerenone","CHEMBL2181927","ENSG00000151623"
"Kerydin","Tavaborole","Anacor","Oxaborole antifungal","Other","Onychomycosis of the toenails","paronychia","EFO_0007421",2014,NA,NA,"TAVABOROLE","CHEMBL443052","NA"
"Kevzara","Sarilumab","Sanofi/Regeneron","IL-6 receptor antagonist","Other","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685",2017,TRUE,TRUE,"SARILUMAB","CHEMBL2108730","ENSG00000160712"
"Keytruda","Pembrolizumab","Merck & Co.","PD1-specific antibody","Oncology","Metastatic melanoma *and others (2021 approval)","metastatic melanoma","EFO_0002617",2014,FALSE,FALSE,"PEMBROLIZUMAB","CHEMBL3137343","ENSG00000188389"
"Kimmtrak","Tebentafusp","Immunocore","gp100 peptide HLA _ CD3 bispecific T-cell engager","Oncology","Uveal melanoma","Uveal Melanoma","EFO_1000616",2022,FALSE,FALSE,"Tebentafusp","CHEMBL4297990","ENSG00000185664"
"Kisqali","Ribociclib","Novartis","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780",2017,TRUE,TRUE,"RIBOCICLIB","CHEMBL3545110","ENSG00000105810, ENSG00000135446"
"Klisyri","Tirbanibulin","Athenex","Microtubule inhibitor","Other","Actinic keratosis","actinic keratosis","EFO_0002496",2020,TRUE,TRUE,"TIRBANIBULIN","CHEMBL571546","ENSG00000197122"
"Korsuva","Difelikefalin","Cara Therapeutics","kappa-Opioid receptor agonist","Other","Pruritus associated with CKD","chronic kidney disease","EFO_0003884",2021,FALSE,FALSE,"Difelikefalin","CHEMBL3989915","ENSG00000082556"
"Koselugo","Selumetinib","AstraZeneca","MEK1/2 kinase inhibitor","Other","Neurofibromatosis type 1","neurofibromatosis type 1","MONDO_0018975",2020,TRUE,TRUE,"SELUMETINIB","CHEMBL1614701","ENSG00000169032, ENSG00000126934"
"Krazati","Adagrasib","Mirati","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",2022,TRUE,TRUE,"Adagrasib","CHEMBL4594350","ENSG00000133703"
"Krintafel","Tafenoquine","Medicines for Malaria Venture/GlaxoSmithKline","8-Aminoquinoline antimalarial","Other","Plasmodium vivax malaria","Plasmodium vivax malaria","EFO_0007445",2018,NA,NA,"TAFENOQUINE","CHEMBL298470","NA"
"Kybella","Deoxycholic acid","Kythera","Cytolytic drug","Other","Fat below the chin","body fat distribution","EFO_0004341",2015,NA,NA,"DEOXYCHOLIC ACID","CHEMBL406393","NA"
"Kynamro","Mipomersen","Genzyme","Oligonucleotide inhibitor of apolipoprotein B100 synthesis","Other","Homozygous familial hypercholesterolaemia","homozygous familial hypercholesterolemia","MONDO_0018328",2013,TRUE,TRUE,"MIPOMERSEN","CHEMBL2219536","ENSG00000084674"
"Lampit","Nifurtimox","Bayer","Nitrofuran antiprotozoal","Other","Chagas disease","chagas disease","MONDO_0001444",2020,NA,NA,"NIFURTIMOX","CHEMBL290960","NA"
"Lartruvo","Olaratumab","Eli Lilly","PDGFRalpha-blocking antibody","Oncology","Soft tissue sarcoma","soft tissue sarcoma","EFO_1001968",2016,TRUE,TRUE,"OLARATUMAB","CHEMBL1743049","ENSG00000134853"
"Lenvima","Lenvatinib","Eisai","VEGFR inhibitor","Oncology","Thyroid cancer","thyroid cancer","MONDO_0002108",2015,TRUE,TRUE,"LENVATINIB","CHEMBL1289601","ENSG00000037280, ENSG00000128052, ENSG00000102755"
"Leqvio","Inclisiran","Novartis/Alnylam","PCSK9-targeted siRNA","Other","HeFH or ASCVD","coronary atherosclerosis","MONDO_0021661",2021,TRUE,TRUE,"Inclisiran","CHEMBL3990033","ENSG00000169174"
"Libtayo","Cemiplimab","Regeneron/Sanofi","PD1 antibody","Oncology","CSCC, BCC(*), NSCLC(*)","cutaneous squamous cell carcinoma; basal cell carcinoma; non-small cell lung carcinoma","EFO_1001927; EFO_0004193; EFO_0003060",2018,TRUE,TRUE,"CEMIPLIMAB","CHEMBL4297723","ENSG00000188389"
"Livmarli","Maralixibat","Mirum","IBAT inhibitor","Other","Pruritus in Alagille syndrome","Alagille syndrome","MONDO_0007318",2021,TRUE,TRUE,"Maralixibat","CHEMBL363392","ENSG00000125255"
"Livtencity","Maribavir","Takeda","CMV pUL97 kinase inhibitor","Other","Post-transplant CMV infection",NA,NA,2021,NA,NA,"Maribavir","CHEMBL515408","NA"
"Lokelma","Sodium zirconium cyclosilicate","AstraZeneca","Potassium binder","Other","Hyperkalaemia","hyperkalemia","HP_0002153",2018,NA,NA,"SODIUM ZIRCONIUM CYCLOSILICATE","CHEMBL3301592","NA"
"Lonsurf","Tipiracil; trifluridine","Taiho","Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor","Oncology","Colorectal cancer","colorectal cancer","EFO_0005842",2015,TRUE,TRUE,"TIPIRACIL; TRIFLURIDINE","CHEMBL235668; CHEMBL1129","ENSG00000025708; ENSG00000176890"
"Lorbrena","Lorlatinib","Pfizer","ALK and ROS1 inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",2018,TRUE,TRUE,"LORLATINIB","CHEMBL3286830","ENSG00000171094, ENSG00000143924"
"Lucemyra","Lofexidine","US WorldMeds","beta2-adrenoceptor agonist","Other","Opioid withdrawal","opioid dependence","EFO_0005611",2018,FALSE,FALSE,"LOFEXIDINE","CHEMBL17860","ENSG00000150594, ENSG00000274286, ENSG00000184160"
"Lumakras","Sotorasib","Amgen","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",2021,TRUE,TRUE,"Sotorasib","CHEMBL4535757","ENSG00000133703"
"Lumason","Sulfur hexafluoride lipid-type A microspheres","Bracco","Ultrasound contrast agent","Other","Cardiovascular imaging",NA,NA,2014,NA,NA,"SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES","NA","NA"
"Lumoxiti","Moxetumomab pasudotox","AstraZeneca","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö¬®drug conjugate","Oncology","Hairy cell leukaemia","hairy cell leukemia","EFO_1000956",2018,TRUE,TRUE,"MOXETUMOMAB PASUDOTOX","CHEMBL1743043","ENSG00000167658, ENSG00000012124"
"Lunsumio","Mosunetuzumab","Roche/Genentech","CD20 _ CD3 bispecific antibody","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906",2022,TRUE,TRUE,"Mosunetuzumab","CHEMBL4297788","ENSG00000167286, ENSG00000156738, ENSG00000198851, ENSG00000160654"
"Lupkynis","Voclosporin","Aurinia","Calcineurin inhibitor","Other","Lupus nephritis","lupus nephritis","EFO_0005761",2021,TRUE,TRUE,"Voclosporin","CHEMBL2218919","ENSG00000138814"
"Lutathera","Lutetium Lu 177 dotatate","Advanced Accelerator Applications/Novartis","Somatostatin receptor-targeted radiopharmaceutical","Oncology","GEP-NETs","digestive system neuroendocrine neoplasm","MONDO_0024503",2018,TRUE,TRUE,"LUTETIUM LU 177 DOTATATE","CHEMBL3989924","ENSG00000139874, ENSG00000162009, ENSG00000278195, ENSG00000132671, ENSG00000180616"
"Luzu","Luliconazole","Medicis","Azole antifungal","Other","Interdigital tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum","tinea","EFO_0007510",2013,NA,NA,"LULICONAZOLE","CHEMBL2105689","NA"
"Lybalvi","Olanzapine; samidorphan","Alkermes","Atypical antipsychotic and opioid antagonist","Other","Schizophrenia and bipolar I disorder","Schizophrenia; bipolar I disorder","MONDO_0005090; EFO_0009963",2021,TRUE,TRUE,"samidorphan; Olanzapine","CHEMBL426084; CHEMBL715","ENSG00000112038, ENSG00000116329, ENSG00000082556; ENSG00000102468, ENSG00000147246, ENSG00000151577, ENSG00000069696, ENSG00000149295"
"Lymphoseek kit","Technetium TC 99m tilmanocept","Navidea","Radioactive diagnostic agent","Other","Lymphatic mapping in patients with breast cancer or melanoma","breast cancer; melanoma","MONDO_0007254; EFO_0000756",2013,FALSE,FALSE,"TECHNETIUM TC 99M TILMANOCEPT","CHEMBL2108726","ENSG00000260314"
"Lynparza","Olaparib","AstraZeneca","PARP inhibitor","Oncology","Advanced BRCA-mutated ovarian cancer","ovarian cancer","MONDO_0008170",2014,TRUE,TRUE,"OLAPARIB","CHEMBL521686","ENSG00000143799, ENSG00000041880, ENSG00000129484"
"Lytgobi","Futibatinib","Taiho Oncology","FGFR kinase inhibitor","Oncology","FGFR2-aberrant intrahepatic cholangiocarcinoma","intrahepatic cholangiocarcinoma","EFO_1001961",2022,TRUE,TRUE,"Futibatinib","CHEMBL3701238","ENSG00000068078, ENSG00000077782, ENSG00000160867, ENSG00000066468"
"Macrilen","Macimorelin","Aeterna Zentaris","Growth hormone secretagogue receptor agonist","Other","Diagnosis of adult growth hormone deficiency","short stature due to GHSR deficiency","MONDO_0014403",2017,TRUE,TRUE,"MACIMORELIN","CHEMBL278623","ENSG00000121853"
"Margenza","Margetuximab","MacroGenics","HER2-directed mAb","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",2020,TRUE,TRUE,"MARGETUXIMAB","CHEMBL2364649","ENSG00000141736"
"Mavyret","Glecaprevir; pibrentasvir","AbbVie","NS3/4A protease inhibitor plus a NS5A inhibitor","Other","HCV","hepatitis C virus infection","EFO_0003047",2017,NA,NA,"GLECAPREVIR; PIBRENTASVIR","CHEMBL3545363; CHEMBL3545123","NA; NA"
"Mayzent","Siponimod","Novartis","S1P receptor modulator","Other","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929",2019,FALSE,FALSE,"SIPONIMOD","CHEMBL2336071","ENSG00000170989"
"Mekinist","Trametinib","GSK","MEK1 and MEK2 kinase inhibitor","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617",2013,TRUE,TRUE,"TRAMETINIB","CHEMBL2103875","ENSG00000169032, ENSG00000126934"
"Mektovi","Binimetinib","Array BioPharma","MEK inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756",2018,TRUE,TRUE,"BINIMETINIB","CHEMBL3187723","ENSG00000169032, ENSG00000126934"
"Mepsevii","Vestronidase alfa","Ultragenyx","Recombinant human lysosomal ‚âà√≠‚Äö√¢¬ß-glucuronidase","Other","Mucopolysaccharidosis VII","mucopolysaccharidosis type 7","MONDO_0009662",2017,TRUE,TRUE,"VESTRONIDASE ALFA","CHEMBL3707382","ENSG00000169919"
"Monjuvi","Tafasitamab","MorphoSys","CD19-directed mAb","Oncology","DLBCL","diffuse large b-cell lymphoma","EFO_0000403",2020,TRUE,TRUE,"TAFASITAMAB","CHEMBL4298047","ENSG00000177455"
"Motegrity","Prucalopride","Shire/Takeda","5-HT4-receptor agonist","Other","Chronic idiopathic constipation","constipation disorder","MONDO_0002203",2018,FALSE,FALSE,"PRUCALOPRIDE","CHEMBL117287","ENSG00000164270"
"Mounjaro","Tirzepatide","Eli Lilly","GIP receptor and GLP1 receptor agonist","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2022,TRUE,TRUE,"Tirzepatide","CHEMBL4297839","ENSG00000010310, ENSG00000112164"
"Movantik","Naloxegol","AstraZeneca","Opioid-receptor antagonist","Other","Opioid-induced constipation","Constipation","HP_0002019",2014,FALSE,FALSE,"NALOXEGOL","CHEMBL2219418","ENSG00000112038"
"Moxidectin","Moxidectin","Medicines Development for Global Health","Antihelmintic GABA receptor and glutamate channel modulator","Other","River blindness","ocular onchocerciasis","EFO_0007398",2018,NA,NA,"MOXIDECTIN","CHEMBL2104415","NA"
"Mulpleta","Lusutrombopag","Shionogi","Thrombopoietin receptor agonist","Other","Thrombocytopenia","thrombocytopenia","HP_0001873",2018,TRUE,TRUE,"LUSUTROMBOPAG","CHEMBL2107831","ENSG00000117400"
"Myalept","Metreleptin","Amylin","Leptin analogue","Other","Leptin deficiency in patients with congenital or acquired generalized lipodystrophy","congenital generalized lipodystrophy","EFO_1000681",2014,TRUE,TRUE,"METRELEPTIN","CHEMBL2107857","ENSG00000116678"
"Natpara","Parathyroid hormone","NPS Pharma","Hormonal injection","Other","Hypocalcaemia in patients with hypoparathyroidism","hypoparathyroidism; Hypocalcemia","EFO_0009451; HP_0002901",2015,TRUE,TRUE,"PARATHYROID HORMONE","CHEMBL2108078","ENSG00000160801"
"Nerlynx","Neratinib","Puma Biotechnology","EGFR, HER2 and HER4 irreversible kinase inhibitor","Oncology","HER2-overexpressed breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",2017,TRUE,TRUE,"NERATINIB","CHEMBL180022","ENSG00000178568, ENSG00000146648, ENSG00000141736"
"Nesina","Alogliptin","Takeda","DPP4 inhibitor","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2013,TRUE,TRUE,"ALOGLIPTIN","CHEMBL376359","ENSG00000197635"
"Netspot","Gallium Ga-68 dotatate","Advanced Accelerator Applications","Radioactive diagnostic","Other","Neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901",2016,TRUE,FALSE,"GALLIUM GA-68 DOTATATE","CHEMBL4297340","ENSG00000180616"
"Neuraceq","Florbetaben-F18","Piramal Imaging","Radioactive diagnostic agent","Other","Imaging of the brain to estimate density of neuritic amyloid-beta plaques","neuritic plaque measurement; Alzheimer disease","EFO_0006798; MONDO_0004975",2014,TRUE,TRUE,"FLORBETABEN-F18","CHEMBL566752","ENSG00000142192"
"Nexletol","Bempedoic acid","Esperion Therapeutics","ACL inhibitor","Other","HeFH or atherosclerotic cardiovascular disease","atherosclerosis; familial hypercholesterolemia","EFO_0003914; EFO_0004911",2020,FALSE,FALSE,"BEMPEDOIC ACID","CHEMBL3545313","ENSG00000131473"
"NexoBrid","Anacaulase","Mediwound","Proteolytic enzymes from pineapple plants","Other","Eschar removal after thermal burns",NA,NA,2022,NA,NA,"Anacaulase","NA","NA"
"Nextstellis","Drospirenone; estetrol","Mayne Pharma","Spironolactone and oestrogen analogues","Other","To prevent pregnancy","reproductive behaviour measurement","EFO_0007862",2021,TRUE,TRUE,"Drospirenone; estetrol","CHEMBL1509; CHEMBL1230314","ENSG00000151623, ENSG00000082175; ENSG00000091831, ENSG00000140009"
"Nexviazyme","Avalglucosidase alfa","Sanofi","Recombinant alpha-glucosidase","Other","Pompe disease","glycogen storage disease II","MONDO_0009290",2021,TRUE,TRUE,"Avalglucosidase alfa","CHEMBL4594320","ENSG00000171298"
"Ninlaro","Ixazomib","Takeda","Oral proteasome inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2015,TRUE,TRUE,"IXAZOMIB","CHEMBL2141296","ENSG00000165916, ENSG00000240065, ENSG00000159377, ENSG00000108671, ENSG00000100804, ENSG00000161057, ENSG00000154611, ENSG00000159352, ENSG00000100902, ENSG00000013275, ENSG00000173692, ENSG00000101182, ENSG00000103035, ENSG00000129084, ENSG00000142507, ENSG00000222028, ENSG00000197170, ENSG00000175166, ENSG00000205220, ENSG00000100764, ENSG00000277791, ENSG00000136930, ENSG00000099341, ENSG00000163636, ENSG00000185627, ENSG00000127922, ENSG00000115233, ENSG00000087191, ENSG00000108344, ENSG00000204264, ENSG00000100519, ENSG00000100567, ENSG00000143106, ENSG00000126067, ENSG00000130706, ENSG00000106588, ENSG00000008018, ENSG00000041357"
"Northera","Droxidopa","Lundbeck","Synthetic amino-acid precursor of noradrenaline; MOA unknown","Other","Light-headedness in patients with neurogenic orthostatic hypotension","primary orthostatic hypotension","MONDO_0015914",2014,TRUE,TRUE,"DROXIDOPA","CHEMBL2103827","ENSG00000169252, ENSG00000170214, ENSG00000043591, ENSG00000120907, ENSG00000274286, ENSG00000184160, ENSG00000188778, ENSG00000150594, ENSG00000171873"
"Nourianz","Istradefylline","Kyowa Kirin","Adenosine receptor antagonist","Other","Parkinson disease episodes","Parkinson disease","MONDO_0005180",2019,TRUE,TRUE,"ISTRADEFYLLINE","CHEMBL431770","ENSG00000128271"
"Nubeqa","Darolutamide","Bayer","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315",2019,TRUE,TRUE,"DAROLUTAMIDE","CHEMBL4297185","ENSG00000169083"
"Nucala","Mepolizumab","GlaxoSmithKline","IL-5 antagonist","Other","Severe asthma","Status Asthmaticus","EFO_0008590",2015,TRUE,TRUE,"MEPOLIZUMAB","CHEMBL2108429","ENSG00000113525"
"Nulibry","Fosdenopterin","BridgeBio","cPMP","Other","MoCD type A","sulfite oxidase deficiency due to molybdenum cofactor deficiency","MONDO_0020480",2021,TRUE,TRUE,"Fosdenopterin","CHEMBL2338675","ENSG00000164172"
"Nuplazid","Pimavanserin","Acadia Pharmaceuticals","Atypical antipsychotic","Other","Hallucinations and delusions associated with Parkinson disease psychosis","Parkinson disease; psychosis","MONDO_0005180; EFO_0005407",2016,TRUE,TRUE,"PIMAVANSERIN","CHEMBL2111101","ENSG00000102468"
"Nurtec ODT","Rimegepant","Biohaven","CGRP receptor antagonist","Other","Migraine","migraine disorder","MONDO_0005277",2020,TRUE,TRUE,"RIMEGEPANT","CHEMBL2178422","ENSG00000064989"
"Nuzyra","Omadacycline","Paratek Pharmaceuticals","Tetracycline antibiotic","Other","CABP and ABSSSI","bacterial pneumonia; skin disease caused by bacterial infection","EFO_1001272; MONDO_0024295",2018,NA,NA,"OMADACYCLINE","CHEMBL1689772","NA"
"Ocaliva","Obeticholic acid","Intercept","FXR agonist","Other","Primary biliary cholangitis","primary biliary cirrhosis","EFO_1001486",2016,TRUE,TRUE,"OBETICHOLIC ACID","CHEMBL566315","ENSG00000012504"
"Ocrevus","Ocrelizumab","Roche/Genentech","CD20-directed cytolytic antibody","Other","Relapsing or primary progressive forms of multiple sclerosis","chronic progressive multiple sclerosis","EFO_0003840",2017,FALSE,FALSE,"OCRELIZUMAB","CHEMBL2108041","ENSG00000156738"
"Odomzo","Sonidegib","Novartis","Smoothened inhibitor","Oncology","Basal cell carcinoma","basal cell carcinoma","EFO_0004193",2015,TRUE,TRUE,"SONIDEGIB","CHEMBL2105737","ENSG00000128602"
"Ofev","Nintedanib","Boehringer Ingelheim","Kinase inhibitor against PDGFRs, FGFRs, VEGFRs and FLT3","Other","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768",2014,TRUE,TRUE,"NINTEDANIB","CHEMBL502835","ENSG00000102755, ENSG00000037280, ENSG00000128052, ENSG00000066468, ENSG00000077782, ENSG00000160867, ENSG00000134853, ENSG00000113721, ENSG00000068078"
"Olinvyk","Oliceridine","Trevena","Opioid receptor agonist","Other","Acute pain","pain","EFO_0003843",2020,FALSE,FALSE,"OLICERIDINE","CHEMBL2443262","ENSG00000112038"
"Olumiant","Baricitinib","Incyte/Eli Lilly","JAK inhibitor","Other","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685",2018,TRUE,TRUE,"BARICITINIB","CHEMBL2105759","ENSG00000096968, ENSG00000162434"
"Olysio","Simeprevir","Janssen","HCV NS3/4A protease inhibitor","Other","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047",2013,NA,NA,"SIMEPREVIR","CHEMBL501849","NA"
"Omegaven","Fish oil triglycerides","Fresenius","Mixture of fatty acids","Other","Parenteral nutrition-associated cholestasis","cholestasis","MONDO_0001751",2018,NA,NA,"FISH OIL TRIGLYCERIDES","CHEMBL4297535","NA"
"Omlonti","Omidenepag isopropyl","Santen","Prostaglandin E2 receptor agonist","Other","Intraocular pressure in open-angle glaucoma or ocular hypertension","ocular hypertension, open-angle glaucoma","EFO_1001069; EFO_0004190",2022,FALSE,FALSE,"Omidenepag isopropyl","CHEMBL4297666","ENSG00000125384"
"Ongentys","Opicapone","Neurocrine","COMT inhibitor","Other","Parkinson disease","parkinson disease","MONDO_0005180",2020,TRUE,TRUE,"OPICAPONE","CHEMBL1089318","ENSG00000093010"
"Onpattro","Patisiran","Alnylam Pharmaceuticals","TTR-directed small interfering RNA","Other","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132",2018,TRUE,TRUE,"PATISIRAN","CHEMBL3989987","ENSG00000118271"
"Opdivo","Nivolumab","Bristol-Myers Squibb","PD1 inhibitor","Oncology","Unresectable or metastatic melanoma","metastatic melanoma","EFO_0002617",2014,FALSE,FALSE,"NIVOLUMAB","CHEMBL2108738","ENSG00000188389"
"Opdualag","Relatlimab; nivolumab","Bristol Myers Squibb","LAG3-targeted mAb plus PD1-targeted mAb","Oncology","Melanoma","melanoma","EFO_0000756",2022,TRUE,TRUE,"Relatlimab; nivolumab","CHEMBL3990044; CHEMBL2108738","ENSG00000089692; ENSG00000188389"
"Opsumit","Macitentan","Actelion","Endothelin receptor antagonist","Other","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361",2013,TRUE,TRUE,"MACITENTAN","CHEMBL2103873","ENSG00000136160, ENSG00000151617"
"Orbactiv","Oritavancin","The Medicines Company","Semi-synthetic lipoglycopeptide","Other","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849",2014,NA,NA,"ORITAVANCIN","CHEMBL1688530","NA"
"Orgovyx","Relugolix","Myovant Sciences","GnRH receptor antagonist","Oncology","Prostate cancer","prostate cancer","MONDO_0008315",2020,TRUE,TRUE,"RELUGOLIX","CHEMBL1800159","ENSG00000109163"
"Orilissa","Elagolix sodium","AbbVie","GnRH receptor antagonist","Other","Pain associated with endometriosis","adenomyosis; pain","MONDO_0010888; EFO_0003843",2018,TRUE,TRUE,"ELAGOLIX SODIUM","CHEMBL502182","ENSG00000109163"
"Orkambi","Ivacaftor; lumacaftor","Vertex","CFTR potentiator plus CFTR corrector","Other","Cystic fibrosis in patients with homozygous DF508 CFTR mutation","cystic fibrosis","MONDO_0009061",2015,TRUE,TRUE,"IVACAFTOR; LUMACAFTOR","CHEMBL2010601; CHEMBL2103870","ENSG00000001626; ENSG00000001626"
"Orladeyo","Berotralstat","BioCryst","Plasma kallikrein inhibitor","Other","Hereditary angioedema",NA,"MONDO_0019623",2020,FALSE,FALSE,"BEROTRALSTAT","CHEMBL4594271","ENSG00000164344"
"Osphena","Ospemifene","Shionogi","Oestrogen receptor modulator","Other","Moderate to severe dyspareunia due to menopause","Dyspareunia; menopause","HP_0030016; EFO_0003922",2013,TRUE,TRUE,"OSPEMIFENE","CHEMBL2105395","ENSG00000140009, ENSG00000091831"
"Otezla","Apremilast","Celgene","Phosphodiesterase 4 inhibitor","Other","Psoriatic arthritis and plaque psoriasis","psoriatic arthritis; psoriasis vulgaris","EFO_0003778; EFO_1001494",2014,TRUE,TRUE,"APREMILAST","CHEMBL514800","ENSG00000184588, ENSG00000065989, ENSG00000105650, ENSG00000113448"
"Oxbryta","Voxelotor","Global Blood Therapeutics","Haemoglobin S polymerization inhibitor","Other","SCD (sickle cell disease)","sickle cell anemia","MONDO_0011382",2019,TRUE,TRUE,"VOXELOTOR","CHEMBL4101807","ENSG00000206172, ENSG00000244734, ENSG00000188536"
"Oxervate","Cenegermin","Domp‚Äö√†√∂¬¨¬©","Recombinant NGF","Other","Neurotrophic keratitis","keratitis","EFO_0009449",2018,TRUE,TRUE,"CENEGERMIN","CHEMBL4297852","ENSG00000140538, ENSG00000148053, ENSG00000198400"
"Oxlumo","Lumasiran","Alnylam","HAO1-directed siRNA","Other","Hyperoxaluria type 1","primary hyperoxaluria type 1","MONDO_0009823",2020,FALSE,FALSE,"LUMASIRAN","CHEMBL4297779","ENSG00000101323"
"Ozempic","Semaglutide","Novo Nordisk","GLP1 receptor agonist","Other","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148",2017,TRUE,TRUE,"SEMAGLUTIDE","CHEMBL2108724","ENSG00000112164"
"PSMA-11 Ga-68","PSMA-11 Ga-68","UCLA","Radioactive diagnostic","Other","Imaging, prostate cancer","prostate carcinoma","EFO_0001663",2020,TRUE,TRUE,"PSMA-11 GA-68","CHEMBL4297335","ENSG00000142515"
"Padcev","Enfortumab vedotin","Astellas","Nectin-4-directed ADC","Oncology","Urothelial cancers","urothelial neoplasm","MONDO_0024337",2019,TRUE,TRUE,"ENFORTUMAB VEDOTIN","CHEMBL3301589","ENSG00000143217, ENSG00000101162, ENSG00000167552, ENSG00000261456, ENSG00000127824, ENSG00000123416, ENSG00000258947, ENSG00000198033, ENSG00000188229, ENSG00000152086, ENSG00000137267, ENSG00000104833, ENSG00000167553, ENSG00000137285, ENSG00000196230, ENSG00000176014"
"Palynziq","Pegvaliase","BioMarin Pharmaceutical","PAL replacement therapy","Other","Phenylketonuria","phenylketonuria","MONDO_0009861",2018,NA,NA,"PEGVALIASE","CHEMBL4297802","NA"
"Parsabiv","Etelcalcetide","Amgen/Kai Pharmaceuticals","Calcium-sensing receptor agonist","Other","Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis","hyperparathyroidism","EFO_0008506",2017,TRUE,TRUE,"VELCALCETIDE","CHEMBL3545184","ENSG00000036828"
"Pemazyre","Pemigatinib","Incyte","FGFR1-3 kinase inhibitor","Oncology","Cholangiocarcinoma","cholangiocarcinoma","EFO_0005221",2020,TRUE,TRUE,"PEMIGATINIB","CHEMBL4297522","ENSG00000066468, ENSG00000068078, ENSG00000077782"
"Pepaxto","Melphalan flufenamide","Oncopeptides","Peptide-conjugated alkylating drug","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2021,NA,NA,"Melphalan flufenamide","CHEMBL4303060","NA"
"Pifeltro","Doravirine","Merck & Co.","NNRTI","Other","HIV","hiv infection","EFO_0000764",2018,NA,NA,"DORAVIRINE","CHEMBL2364608","NA"
"Piqray","Alpelisib","Novartis","PI3K inhibitor","Oncology","Breast cancer","breast cancer","MONDO_0007254",2019,TRUE,TRUE,"ALPELISIB","CHEMBL2396661","ENSG00000121879"
"Pizensy","Lactitol","Braintree Labs","Osmotic laxative","Other","Chronic idiopathic constipation","Chronic constipation","HP_0012450",2020,NA,NA,"LACTITOL","CHEMBL1661","NA"
"Plegridy","Peginterferon beta-1A","Biogen Idec","Long-acting interferon-beta1A","Other","Relapsing multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929",2014,FALSE,FALSE,"PEGINTERFERON BETA-1A","CHEMBL2108677","ENSG00000159110, ENSG00000142166"
"Pluvicto","Lutetium Lu-177 vipivotide tetraxetan","Novartis","PSMA-binding radioligand therapeutic agent","Oncology","PSMA-positive prostate cancer","prostate carcinoma","EFO_0001663",2022,TRUE,TRUE,"Lutetium Lu-177 vipivotide tetraxetan","CHEMBL4594406","ENSG00000142515"
"Polivy","Polatuzumab vedotin","Roche","CD79b-directed ADC","Oncology","Diffuse large B-cell lymphoma","diffuse large b-cell lymphoma","EFO_0000403",2019,TRUE,TRUE,"POLATUZUMAB VEDOTIN","CHEMBL3301582","ENSG00000198033, ENSG00000167552, ENSG00000261456, ENSG00000176014, ENSG00000258947, ENSG00000123416, ENSG00000101162, ENSG00000188229, ENSG00000152086, ENSG00000007312, ENSG00000137285, ENSG00000167553, ENSG00000196230, ENSG00000137267, ENSG00000127824, ENSG00000104833"
"Pomalyst","Pomalidomide","Celgene","Immunomodulatory antineoplastic agent","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2013,TRUE,TRUE,"POMALIDOMIDE","CHEMBL43452","ENSG00000167986, ENSG00000139842, ENSG00000113851, ENSG00000100387"
"Ponvory","Ponesimod","J&J","S1P receptor modulator","Other","Relapsing multiple sclerosis","multiple sclerosis","MONDO_0005301",2021,TRUE,TRUE,"Ponesimod","CHEMBL1096146","ENSG00000170989"
"Portrazza","Necitumumab","Eli Lilly","EGFR antagonist","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",2015,TRUE,TRUE,"NECITUMUMAB","CHEMBL1743047","ENSG00000146648"
"Poteligeo","Mogamulizumab","Kyowa Hakko Kirin","CCR4 antibody","Oncology","mycosis fungoides or Sezary syndrome","mycosis fungoides","EFO_1001051",2018,TRUE,TRUE,"MOGAMULIZUMAB","CHEMBL1743041","ENSG00000183813"
"Praluent","Alirocumab","Sanofi","PCSK9 inhibitor","Other","LDL lowering","LDL cholesterol change measurement","EFO_0007804",2015,TRUE,TRUE,"ALIROCUMAB","CHEMBL2109540","ENSG00000169174"
"Praxbind","Idarucizumab","Boehringer Ingelheim","Dabigatran-binding mAb fragment","Other","Reversal of anticoagulant effects of dabigatran","response to anticoagulant","GO_0061476",2015,NA,NA,"IDARUCIZUMAB","CHEMBL3544996","NA"
"Pretomanid","Pretomanid","Pfizer/Mylan","Antimycobacterial","Other","Tuberculosis","tuberculosis","MONDO_0018076",2019,NA,NA,"PRETOMANID","CHEMBL227875","NA"
"Prevymis","Letermovir","Merck & Co.","CMV DNA terminase complex inhibitor","Other","Prophylaxis of CMV (cytomegalovirus)","cytomegalovirus infection","EFO_0001062",2017,NA,NA,"LETERMOVIR","CHEMBL1241951","NA"
"Pylarify","Piflufolastat F-18","Progenics","Radiolabelled PSMA imaging agent","Other","Prostate cancer imaging","prostate carcinoma","EFO_0001663",2021,FALSE,FALSE,"Piflufolastat F-18","CHEMBL4297334","ENSG00000086205"
"Pyrukynd","Mitapivat","Agios","Pyruvate kinase activator","Other","Haemolytic anaemia due to PK deficiency","hemolytic anemia","EFO_0005558",2022,TRUE,TRUE,"Mitapivat","CHEMBL4299940","ENSG00000143627"
"Qelbree","Viloxazine","Supernus","SNRI","Other","ADHD","attention deficit hyperactivity disorder","EFO_0003888",2021,FALSE,FALSE,"Viloxazine","CHEMBL306700","ENSG00000103546"
"Qinlock","Ripretinib","Deciphera","KIT and PDGFRA kinase inhibitor","Oncology","GIST","gastrointestinal stromal tumor","MONDO_0011719",2020,TRUE,TRUE,"RIPRETINIB","CHEMBL4216467","ENSG00000157404, ENSG00000134853"
"Qulipta","Atogepant","AbbVie","CGRP receptor antagonist","Other","Episodic migraine","migraine disorder","MONDO_0005277",2021,TRUE,TRUE,"Atogepant","CHEMBL3991065","ENSG00000064989"
"Quviviq","Daridorexant","Idorsia","Orexin receptor antagonist","Other","Insomnia","insomnia","EFO_0004698",2022,TRUE,TRUE,"Daridorexant","CHEMBL4297590","ENSG00000137252, ENSG00000121764"
"Radicava","Edaravone","Mitsubishi Tanabe","Unknown (radical scavenger)","Other","ALS (amyotrophic lateral sclerosis)","amyotrophic lateral sclerosis","MONDO_0004976",2017,NA,NA,"EDARAVONE","CHEMBL290916","NA"
"Rapivab","Peramivir","BioCryst","Neuraminidase inhibitor","Other","Influenza infection","influenza","EFO_0007328",2014,NA,NA,"PERAMIVIR; PERAMIVIR","CHEMBL3989402; CHEMBL139367","NA; NA"
"Reblozyl","Luspatercept","Celgene/BMS","Erythroid maturation agent","Other","Anaemia in beta-thalassaemia","beta thalassemia; anemia","MONDO_0019402; MONDO_0002280",2019,TRUE,TRUE,"LUSPATERCEPT","CHEMBL3039545","ENSG00000105329, ENSG00000092969, ENSG00000119699"
"Recarbrio","Cilastatin; imipenem; relebactam","Merck & Co.","A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor","Other","Complicated urinary tract and complicated intra-abdominal infections","urinary tract infection","EFO_0003103",2019,NA,FALSE,"CILASTATIN; IMIPENEM; RELEBACTAM","CHEMBL766; CHEMBL148; CHEMBL3301605","ENSG00000015413; NA; NA"
"Relyvrio","Sodium phenylbutyrate; taurursodiol","Amylyx","Mechanism unknown","Other","Amyotrophic lateral sclerosis","amyotrophic lateral sclerosis","MONDO_0004976",2022,NA,NA,"Sodium phenylbutyrate; taurursodiol","CHEMBL1746; CHEMBL272427","NA; NA"
"Repatha","Evolocumab","Amgen","PCSK9 inhibitor","Other","LDL lowering","LDL cholesterol change measurement","EFO_0007804",2015,TRUE,TRUE,"EVOLOCUMAB","CHEMBL2364655","ENSG00000169174"
"Retevmo","Selpercatinib","Eli Lilly/Loxo Oncology","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC and thyroid cancer","non-small cell lung carcinoma; thyroid cancer","EFO_0003060; MONDO_0002108",2020,TRUE,TRUE,"SELPERCATINIB","CHEMBL4559134","ENSG00000108091, ENSG00000165731, ENSG00000170759"
"Revcovi","Elapegademase","Leadiant Biosciences","Recombinant adenosine deaminase","Other","ADA-SCID","severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency","MONDO_0007064",2018,TRUE,TRUE,"ELAPEGADEMASE","CHEMBL3990026","ENSG00000196839"
"Rexulti","Brexpiprazole","Otsuka","Atypical antipsychotic","Other","MDD and schizophrenia","major depressive disorder; schizophrenia","MONDO_0002009; MONDO_0005090",2015,TRUE,TRUE,"BREXPIPRAZOLE","CHEMBL2105760","ENSG00000149295, ENSG00000178394, ENSG00000102468"
"Reyvow","Lasmiditan","Eli Lilly","Serotonin (5-HT) 1F receptor agonist","Other","Migraine with or without aura","migraine disorder","MONDO_0005277",2019,FALSE,FALSE,"LASMIDITAN","CHEMBL3039520","ENSG00000179097"
"Rezlidhia","Olutasidenib","Rigel/Forma","IDH1 inhibitor","Oncology","IDH1-mutated AML","acute myeloid leukemia","EFO_0000222",2022,TRUE,TRUE,"Olutasidenib","CHEMBL4297610","ENSG00000138413"
"Rezurock","Belumosudil","Kadmon","ROCK2 kinase inhibitor","Other","Chronic GVHD","graft versus host disease","MONDO_0013730",2021,FALSE,FALSE,"Belumosudil","CHEMBL2005186","ENSG00000134318, ENSG00000067900"
"Rhopressa","Netarsudil","Aerie Pharmaceuticals","RHO kinase inhibitor","Other","Open-angle glaucoma or ocular hypertension","open-angle glaucoma; ocular hypertension","EFO_0004190; EFO_1001069",2017,FALSE,FALSE,"NETARSUDIL","CHEMBL4594250","ENSG00000134318, ENSG00000067900"
"Rinvoq","Upadacitinib","AbbVie","JAK inhibitor","Other","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685",2019,TRUE,TRUE,"UPADACITINIB","CHEMBL3622821","ENSG00000162434, ENSG00000096968, ENSG00000105397, ENSG00000105639"
"Rolvedon","Eflapegrastim","Spectrum","Leukocyte growth factor","Other","Incidence of infection in non-myeloid malignancies, with myelosuppressive drugs","infection","EFO_0000544",2022,TRUE,TRUE,"Eflapegrastim","CHEMBL3833384","ENSG00000119535"
"Rozlytrek","Entrectinib","Roche","TRKA, TRKB, TRKC, ROS1 and ALK inhibitor","Oncology","NTRK fusion-positive solid tumours and ROS1-positive NSCLC","non-small cell lung carcinoma","EFO_0003060",2019,TRUE,TRUE,"ENTRECTINIB","CHEMBL1983268","ENSG00000148053, ENSG00000198400, ENSG00000140538, ENSG00000047936, ENSG00000171094"
"Rubraca","Rucaparib","Clovis Oncology","PARP inhibitor","Oncology","BRCA-positive ovarian cancer","ovarian cancer","MONDO_0008170",2016,TRUE,TRUE,"RUCAPARIB","CHEMBL1173055","ENSG00000041880, ENSG00000129484, ENSG00000143799"
"Rukobia","Fostemsavir","ViiV Healthcare","Attachment inhibitor","Other","HIV","hiv infection","EFO_0000764",2020,NA,NA,"FOSTEMSAVIR","CHEMBL3301594","NA"
"Rybrevant","Amivantamab","J&J","EGFRxMETR bispecific antibody","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",2021,TRUE,TRUE,"Amivantamab","CHEMBL4297774","ENSG00000105976, ENSG00000146648"
"Rydapt","Midostaurin","Novartis","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia, FLT3 internal tandem duplication","MONDO_0100415",2017,TRUE,TRUE,"MIDOSTAURIN","CHEMBL608533","ENSG00000163932, ENSG00000115825, ENSG00000166501, ENSG00000171132, ENSG00000163558, ENSG00000184304, ENSG00000065675, ENSG00000126583, ENSG00000027075, ENSG00000067606, ENSG00000154229, ENSG00000128052, ENSG00000122025, ENSG00000157404, ENSG00000134853, ENSG00000113721"
"Rylaze","Asparaginase erwinia chrysanthemi","Jazz","Recombinant asparagine-specific enzyme","Oncology","ALL and LBL, in patients allergic to E. coli-derived products","acute lymphoblastic leukemia; lymphoblastic lymphoma","EFO_0000220; MONDO_0000873",2021,NA,NA,"Asparaginase erwinia chrysanthemi","CHEMBL1863514","NA"
"Saphnelo","Anifrolumab","AstraZeneca","IFNAR-targeted mAb","Other","SLE","systemic lupus erythematosus","MONDO_0007915",2021,TRUE,TRUE,"Anifrolumab","CHEMBL2364653","ENSG00000142166"
"Sarclisa","Isatuximab","Sanofi","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2020,TRUE,TRUE,"ISATUXIMAB","CHEMBL3545131","ENSG00000004468"
"Savaysa","Edoxaban","Daiichi Sankyo","Factor Xa inhibitor","Other","Risk of stroke and systemic embolism in NVAF, and deep vein thrombosis","atrial fibrillation; deep vein thrombosis","EFO_0000275; EFO_0003907",2015,TRUE,TRUE,"EDOXABAN","CHEMBL1269025","ENSG00000126218"
"Scemblix","Asciminib","Novartis","ABL/BCR-ABL1  kinase inhibitor","Oncology","Ph+ CML","Blast Phase Chronic Myelogenous Leukemia; BCR-ABL1 Positive","EFO_1000131",2021,TRUE,TRUE,"Asciminib","CHEMBL4208229","ENSG00000097007"
"Scenesse","Afamelanotide","Clinuvel","Melanocortin 1 receptor agonist","Other","Erythropoietic protoporphyria","erythropoietic protoporphyria","MONDO_0001676",2019,TRUE,TRUE,"AFAMELANOTIDE","CHEMBL441738","ENSG00000258839"
"Seysara","Sarecycline","Allergan","Tetracycline antibiotic","Other","Severe acne vulgaris","acne","EFO_0003894",2018,NA,NA,"SARECYCLINE","CHEMBL2364632","NA"
"Siliq","Brodalumab","Valeant Pharmaceuticals","IL-17RA antagonist","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2017,TRUE,TRUE,"BRODALUMAB","CHEMBL1742996","ENSG00000177663"
"Sivextro","Tedizolid","Cubist","Oxazolidinone-class antibacterial","Other","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849",2014,NA,NA,"TEDIZOLID","CHEMBL1257051","NA"
"Skyrizi","Risankizumab","AbbVie","IL-23 antagonist","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2019,TRUE,TRUE,"RISANKIZUMAB","CHEMBL3990029","ENSG00000110944, ENSG00000113302"
"Skytrofa","Lonapegsomatropin","Ascendis Pharma","PEGylated human growth hormone","Other","Growth failure due to GHD","Growth delay","HP_0001510",2021,TRUE,TRUE,"Lonapegsomatropin","CHEMBL4298185","ENSG00000112964"
"Sogroya","Somapacitan","Novo Nordisk","Growth hormone analogue","Other","Growth hormone deficiency","short stature due to partial GHR deficiency","MONDO_0011420",2020,TRUE,TRUE,"SOMAPACITAN","CHEMBL3707290","ENSG00000112964"
"Solosec","Secnidazole","Lupin","Nitroimidazole antimicrobial","Other","Bacterial vaginosis","bacterial vaginosis","EFO_0003932",2017,NA,NA,"SECNIDAZOLE","CHEMBL498847","NA"
"Sotyktu","Deucravacitinib","Bristol Myers Squibb","TYK2 inhibitor","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2022,TRUE,TRUE,"Deucravacitinib","CHEMBL4435170","ENSG00000105397"
"Sovaldi","Sofosbuvir","Gilead","HCV nucleotide analogue NS5B polymerase inhibitor","Other","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047",2013,NA,NA,"SOFOSBUVIR","CHEMBL1259059","NA"
"Spevigo","Spesolimab","Boehringer Ingelheim","IL-36R-targeted mAb","Other","Generalized pustular psoriasis flares","psoriasis 14, pustular","MONDO_0013626",2022,FALSE,FALSE,"Spesolimab","CHEMBL4297911","ENSG00000115598, ENSG00000196083"
"Spinraza","Nusinersen","Biogen/Ionis Pharmaceuticals","ASO designed to target SMN2 pre-mRNA","Other","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525",2016,TRUE,TRUE,"NUSINERSEN","CHEMBL3301572","ENSG00000205571"
"Steglatro","Ertugliflozin","Merck & Co./Pfizer","SGLT2 inhibitor","Other","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148",2017,TRUE,TRUE,"ERTUGLIFLOZIN","CHEMBL1770248","ENSG00000140675"
"Strensiq","Asfotase alfa","Alexion","Alkaline phosphatase","Other","Hypophosphatasia","hypophosphatasia","MONDO_0018570",2015,TRUE,TRUE,"ASFOTASE ALFA","CHEMBL2108311","ENSG00000162551"
"Striverdi Respimat","Olodaterol","Boehringer Ingelheim","Long-acting beta2-adrenoceptor agonist","Other","COPD","chronic obstructive pulmonary disease","EFO_0000341",2014,TRUE,TRUE,"OLODATEROL","CHEMBL605846","ENSG00000169252"
"Sunlenca","Lenacapavir","Gilead","HIV-1 capsid inhibitor","Other","HIV-1 infection","HIV-1 infection","EFO_0000180",2022,NA,NA,"Lenacapavir","CHEMBL4594438","NA"
"Sunosi","Solriamfetol","Jazz","Dopamine and noradrenaline reuptake inhibitor","Other","Excessive sleepiness due to narcolepsy or obstructive sleep apnoea","hypersomnia; narcolepsy; obstructive sleep apnea","EFO_0005246; MONDO_0021107; EFO_0003918",2019,NA,NA,"SOLRIAMFETOL","CHEMBL4297620","NA"
"Sylvant","Siltuximab","Janssen Biotech","IL-6-specific antibody","Other","Multicentric Castleman's disease","Castleman disease","MONDO_0015564",2014,TRUE,TRUE,"SILTUXIMAB","CHEMBL1743070","ENSG00000136244"
"Symdeko","Tezacaftor; ivacaftor","Vertex Pharmaceuticals","CFTR corrector and CFTR potentiator","Other","Cystic fibrosis","cystic fibrosis","MONDO_0009061",2018,TRUE,TRUE,"TEZACAFTOR; IVACAFTOR","CHEMBL3544914; CHEMBL2010601","ENSG00000001626; ENSG00000001626"
"Symproic","Naldemedine","Shionogi","Opioid antagonist","Other","Opioid-induced constipation","Constipation","HP_0002019",2017,FALSE,FALSE,"NALDEMEDINE","CHEMBL2105755","ENSG00000112038"
"TPOXX","Tecovirimat","SIGA Technologies","Viral p37 protein inhibitor","Other","Smallpox","smallpox","MONDO_0004651",2018,NA,NA,"TECOVIRIMAT","CHEMBL1257073","NA"
"Tabrecta","Capmatinib","Novartis","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",2020,TRUE,TRUE,"CAPMATINIB","CHEMBL3188267","ENSG00000105976"
"Tafinlar","Dabrafenib","GSK","Kinase inhibitor with activity against BRAFV600E, BRAFV600K, BRAFV600D, wild-type BRAF and other kinases","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617",2013,TRUE,TRUE,"DABRAFENIB","CHEMBL2028663","ENSG00000157764"
"Tagrisso","Osimertinib","AstraZeneca","EGFR inhibitor","Oncology","NSCLC with EGFRT790M mutations","non-small cell lung carcinoma","EFO_0003060",2015,TRUE,TRUE,"OSIMERTINIB","CHEMBL3353410","ENSG00000146648"
"Takhzyro","Lanadelumab","Dyax/Shire","Kallikrein antibody","Other","Hereditary angioedema","hereditary angioedema","MONDO_0019623",2018,FALSE,FALSE,"LANADELUMAB","CHEMBL3545189","ENSG00000164344"
"Taltz","Ixekizumab","Eli Lilly","IL-17A antagonist","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2016,FALSE,FALSE,"IXEKIZUMAB","CHEMBL1743034","ENSG00000112115"
"Talzenna","Talazoparib","Pfizer","PARP inhibitor","Oncology","BRCA-mutated HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780",2018,TRUE,TRUE,"TALAZOPARIB","CHEMBL3137320","ENSG00000143799, ENSG00000129484"
"Tanzeum","Albiglutide","GlaxoSmithKline","GLP1-receptor agonist","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2014,TRUE,TRUE,"ALBIGLUTIDE","CHEMBL2107841","ENSG00000112164"
"Tavalisse","Fostamatinib","Rigel Pharmaceuticals","SYK inhibitor","Other","Immune thrombocytopenic purpura","autoimmune thrombocytopenic purpura","EFO_0007160",2018,TRUE,TRUE,"FOSTAMATINIB","CHEMBL2103830","ENSG00000165025"
"Tavneos","Avacopan","ChemoCentryx","Complement 5a receptor antagonist","Other","ANCA-associated vasculitis","Anti-neutrophil cytoplasmic antibody-associated vasculitis","MONDO_0015492",2021,FALSE,FALSE,"Avacopan","CHEMBL3989871","ENSG00000197405"
"Tazverik","Tazemetostat","Epizyme","EZH2 inhibitor","Oncology","Epithelioid sarcoma","epithelioid sarcoma","MONDO_0017387",2020,TRUE,TRUE,"TAZEMETOSTAT","CHEMBL3414621","ENSG00000106462"
"Tecentriq","Atezolizumab","Genentech","PDL1 inhibitor","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528",2016,TRUE,TRUE,"ATEZOLIZUMAB","CHEMBL3707227","ENSG00000120217"
"Tecfidera","Dimethyl fumarate","Biogen Idec","MOA unknown; activates NRF2 pathway","Other","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929",2013,TRUE,TRUE,"DIMETHYL FUMARATE","CHEMBL2107333","ENSG00000079999"
"Tecvayli","Teclistamab","J&J","BCMA _ CD3 bispecific antibody","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2022,TRUE,TRUE,"Teclistamab","CHEMBL4594505","ENSG00000048462, ENSG00000160654, ENSG00000198851, ENSG00000167286"
"Tegsedi","Inotersen","Ionis Pharmaceuticals","TTR-directed antisense oligonucleotide","Other","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132",2018,TRUE,TRUE,"INOTERSEN","CHEMBL4297770","ENSG00000118271"
"Tepezza","Teprotumumab","Horizon Therapeutics","IGF1R-directed mAb","Other","Thyroid eye disease","Graves disease","EFO_0004237",2020,FALSE,FALSE,"TEPROTUMUMAB","CHEMBL1743079","ENSG00000140443"
"Tepmetko","Tepotinib","EMD Serono","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060",2021,TRUE,TRUE,"Tepotinib","CHEMBL3402762","ENSG00000105976"
"Terlivaz","Terlipressin","Mallinckrodt","Vasopressin receptor agonist","Other","Kidney function in hepatorenal syndrome","Hepatorenal syndrome","MONDO_0001382",2022,FALSE,FALSE,"Terlipressin","CHEMBL2135460","ENSG00000166148"
"Tezspire","Tezepelumab","Astrazeneca/Amgen","TSLP-targeted mAb","Other","Severe asthma","asthma","MONDO_0004979",2021,TRUE,TRUE,"Tezepelumab","CHEMBL3707229","ENSG00000145777"
"Tibsovo","Ivosidenib","Agios Pharmaceuticals","IDH1 inhibitor","Oncology","IDH1-mutated AML, Locally Advanced or Metastatic Cholangiocarcinoma (*)","acute myeloid leukemia; cholangiocarcinoma","EFO_0000222; EFO_0005221",2018,TRUE,TRUE,"IVOSIDENIB","CHEMBL3989958","ENSG00000138413"
"Tissueblue","Brilliant Blue G","Dutch Ophthalmic Research","Brilliant Blue G dye","Other","Staining the internal limiting membrane",NA,NA,2019,NA,NA,"BRILLIANT BLUE G","CHEMBL4173394","NA"
"Tivdak","Tisotumab vedotin","Seagen/Genmab","Tissue-factor-directed ADC","Oncology","Cervical cancer","cervical cancer","MONDO_0002974",2021,TRUE,TRUE,"Tisotumab vedotin","CHEMBL4297841","ENSG00000117525, ENSG00000167552, ENSG00000258947, ENSG00000137267, ENSG00000188229, ENSG00000176014, ENSG00000261456, ENSG00000123416, ENSG00000198033, ENSG00000196230, ENSG00000167553, ENSG00000152086, ENSG00000104833, ENSG00000137285, ENSG00000101162, ENSG00000127824"
"Tivicay","Dolutegravir","ViiV","HIV1 integrase strand transfer inhibitor","Other","HIV1 infection in adults and children, in combination with other antiretroviral agents","HIV infection","EFO_0000764",2013,NA,NA,"DOLUTEGRAVIR","CHEMBL1229211","NA"
"Tremfya","Guselkumab","Janssen/Johnson & Johnson","IL-23 blocker","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2017,TRUE,TRUE,"GUSELKUMAB","CHEMBL2364648","ENSG00000113302, ENSG00000110944"
"Tresiba","Insulin degludec","Novo Nordisk","Long-acting insulin","Other","Diabetes","diabetes mellitus","EFO_0000400",2015,TRUE,TRUE,"INSULIN DEGLUDEC","CHEMBL2107869","ENSG00000171105"
"Trikafta","Tezacaftor; elexacaftor; ivacaftor","Vertex","Two CFTR correctors and a CFTR potentiator","Other","Most common gene mutation that causes cystic fibrosis","cystic fibrosis","MONDO_0009061",2019,TRUE,TRUE,"TEZACAFTOR; ELEXACAFTOR; IVACAFTOR","CHEMBL3544914; CHEMBL4298128; CHEMBL2010601","ENSG00000001626; ENSG00000001626; ENSG00000001626"
"Trodelvy","Sacituzumab govitecan","Immunomedics/Gilead","TROP2-directed ADC, with topoisomerase inhibitor","Oncology","Triple-negative breast cancer (and advanced or metastatic urothelial cancer (mUC)*)","triple-negative breast cancer; urothelial carcinoma","EFO_0005537; EFO_0008528",2020,TRUE,TRUE,"SACITUZUMAB GOVITECAN","CHEMBL3545262","ENSG00000198900, ENSG00000184292"
"Trogarzo","Ibalizumab","TaiMed Biologics/Theratechnologies","CD4 antibody","Other","HIV","hiv infection","EFO_0000764",2018,TRUE,TRUE,"IBALIZUMAB","CHEMBL1743029","ENSG00000010610"
"Trulance","Plecanatide","Synergy Pharmaceuticals","Guanylate cyclase C agonist","Other","Chronic idiopathic constipation","Chronic constipation","HP_0012450",2017,FALSE,FALSE,"PLECANATIDE","CHEMBL2103867","ENSG00000070019"
"Trulicity","Dulaglutide","Eli Lilly","GLP1-receptor agonist","Other","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148",2014,TRUE,TRUE,"DULAGLUTIDE","CHEMBL2108027","ENSG00000112164"
"Truseltiq","Infigratinib","BridgeBio","FGFR2 kinase inhibitor","Oncology","FGFR2-mutated bile duct cancer","bile duct cancer","MONDO_0003059",2021,TRUE,TRUE,"Infigratinib","CHEMBL1852688","ENSG00000160867, ENSG00000068078, ENSG00000066468, ENSG00000077782"
"Tukysa","Tucatinib","Seagen","HER2 kinase inhibitor","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294",2020,TRUE,TRUE,"TUCATINIB","CHEMBL3989868","ENSG00000141736"
"Turalio","Pexidartinib","Daiichi Sankyo","CSF1R, KIT and FLT3 inhibitor","Oncology","Tenosynovial giant cell tumour","Tenosynovial Giant Cell Tumor","EFO_1000562",2019,TRUE,TRUE,"PEXIDARTINIB","CHEMBL3813873","ENSG00000182578, ENSG00000122025, ENSG00000157404"
"Tymlos","Abaloparatide","Radius Health","Parathyroid hormone-related protein","Other","Osteoporosis","osteoporosis","EFO_0003882",2017,TRUE,TRUE,"ABALOPARATIDE","CHEMBL3301581","ENSG00000160801"
"Tzield","Teplizumab","Provention Bio","CD3-targeted antibody","Other","Delay onset of type 1 diabetes","type 1 diabetes mellitus","MONDO_0005147",2022,TRUE,TRUE,"Teplizumab","CHEMBL1743078","ENSG00000198851"
"Ubrelvy","Ubrogepant","Allergan","CGRP receptor antagonist","Other","Migraine with or without aura","migraine disorder","MONDO_0005277",2019,TRUE,TRUE,"UBROGEPANT","CHEMBL2364638","ENSG00000064989"
"Ukoniq","Umbralisib","TG Therapeutics","PI3Kdelta and CK1epsilon inhibitor","Oncology","MZL, follicular lymphoma","MZL; follicular lymphoma","EFO_1000630; MONDO_0018906",2021,TRUE,TRUE,"Umbralisib","CHEMBL3948730","ENSG00000171608, ENSG00000097007, ENSG00000213923"
"Ultomiris","Ravulizumab","Alexion","Complement inhibitor","Other","Paroxysmal nocturnal haemoglobinuria, atypical hemolytic uremic syndrome (*), generalized myasthenia gravis AChR+ (*)","paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, Myasthenia gravis","MONDO_0100244; MONDO_0016244; EFO_0004991",2018,TRUE,TRUE,"RAVULIZUMAB","CHEMBL3989986","ENSG00000106804"
"Unituxin","Dinutuximab","United Therapeutics","GD2-binding mAb","Oncology","Neuroblastoma","neuroblastoma","EFO_0000621",2015,NA,NA,"DINUTUXIMAB","CHEMBL3137342","NA"
"Uplizna","Inebilizumab","Viela Bio","CD19-directed mAb","Other","NMOSD","neuromyelitis optica","EFO_0004256",2020,FALSE,FALSE,"INEBILIZUMAB","CHEMBL2109334","ENSG00000177455"
"Uptravi","Selexipag","Actelion","Prostacyclin receptor agonist","Other","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361",2015,FALSE,FALSE,"SELEXIPAG","CHEMBL238804","ENSG00000160013"
"Vabomere","Meropenem; vaborbactam","The Medicines Company/Rempex Pharmaceuticals","Carbapenem antimicrobial plus a ‚âà√≠‚Äö√¢¬ß-lactamase inhibitor","Other","Complicated urinary tract infections","urinary tract infection","EFO_0003103",2017,NA,NA,"MEROPENEM; VABORBACTAM","CHEMBL127; CHEMBL3317857","NA; NA"
"Vabysmo","Faricimab","Roche/Genentech","VEGF _ ANG2 bispecific antibody","Other","nAMD and DME","age-related macular degeneration","EFO_0001365",2022,TRUE,TRUE,"Faricimab","CHEMBL4297750","ENSG00000112715, ENSG00000091879"
"Varubi","Rolapitant","Tesaro","Neurokinin 1 receptor antagonist","Other","Nausea and vomiting associated with chemotherapy","Chemotherapy-induced nausea and vomiting","EFO_0006911",2015,FALSE,FALSE,"ROLAPITANT","CHEMBL3707331","ENSG00000115353"
"Veklury","Remdesivir","Gilead","Nucleotide analogue RNA polymerase inhibitor","Other","COVID-19","covid-19","MONDO_0100096",2020,NA,NA,"REMDESIVIR","CHEMBL4065616","NA"
"Veltassa","Patiromer sorbitex","Relypsa","Potassium binder","Other","Hyperkalaemia","Hyperkalemia","HP_0002153",2015,NA,NA,"PATIROMER SORBITEX","CHEMBL2107840","NA"
"Venclexta","Venetoclax","AbbVie","BCL-2 inhibitor","Oncology","Chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095",2016,TRUE,TRUE,"VENETOCLAX","CHEMBL3137309","ENSG00000171791"
"Verquvo","Vericiguat","Merck & Co./Bayer","sGC stimulator","Other","Chronic heart failure","coronary artery disease","EFO_0001645",2021,TRUE,TRUE,"Vericiguat","CHEMBL4066936","ENSG00000123201, ENSG00000061918, ENSG00000152402, ENSG00000164116"
"Verzenio","Abemaciclib","Eli Lilly","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780",2017,TRUE,TRUE,"ABEMACICLIB","CHEMBL3301610","ENSG00000105810, ENSG00000135446"
"Viberzi","Eluxadoline","Allergan","Mu-opioid receptor agonist","Other","Irritable bowel syndrome","irritable bowel syndrome","EFO_0000555",2015,FALSE,FALSE,"ELUXADOLINE","CHEMBL2159122","ENSG00000112038"
"Viekira Pak","Ombitasvir; paritaprevir; dasabuvir; ritonavir","AbbVie","An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor","Other","Chronic HCV genotype 1 infection","hepatitis C virus infection","EFO_0003047",2014,NA,FALSE,"OMBITASVIR; PARITAPREVIR; DASABUVIR; RITONAVIR","CHEMBL3127326; CHEMBL3391662; CHEMBL3137312; CHEMBL163","NA; NA; NA; ENSG00000021461, ENSG00000160870, ENSG00000106258, ENSG00000160868"
"Viltepso","Viltolarsen","Nippon Shinyaku","Dystrophin splicing modifier","Other","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679",2020,TRUE,TRUE,"VILTOLARSEN","CHEMBL4298062","ENSG00000198947"
"Vimizim","Elosulfase alfa","BioMarin","Hydrolytic lysosomal glycosaminoglycan-specific enzyme","Other","Mucopolysaccharidosis type IVA","mucopolysaccharidosis type 4A","MONDO_0009659",2014,TRUE,TRUE,"ELOSULFASE ALFA","CHEMBL2108676","ENSG00000141012"
"Vitrakvi","Larotrectinib","Loxo Oncology/Bayer","TRKA, TRKB and TRKC inhibitor","Oncology","NTRK-positive solid cancers","salivary gland cancer; soft tissue sarcoma; thyroid cancer","MONDO_0004669; EFO_1001968; MONDO_0002108",2018,TRUE,TRUE,"LAROTRECTINIB","CHEMBL3889654","ENSG00000148053, ENSG00000198400, ENSG00000140538"
"Vivjoa","Oteseconazole","Mycovia","Azole antifungal","Other","Vulvovaginal candidiasis","vulvovaginal candidiasis","EFO_0007543",2022,NA,NA,"Oteseconazole","CHEMBL3311228","NA"
"Vizamyl","Flutemetamol F-18","GE Healthcare","Radioactive diagnostic agent","Other","PET imaging of the brain to estimate beta-amyloid neuritic plaque density in patients who are being evaluated for Alzheimer's disease","neuritic plaque measurement; Alzheimer disease","EFO_0006798; MONDO_0004975",2013,TRUE,TRUE,"FLUTEMETAMOL F-18","CHEMBL2042122","ENSG00000142192"
"Vizimpro","Dacomitinib","Pfizer","EGFR inhibitor","Oncology","EGFR-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060",2018,TRUE,TRUE,"DACOMITINIB","CHEMBL2105719","ENSG00000178568, ENSG00000146648, ENSG00000141736"
"Vonjo","Pacritinib","CTI Biopharma","JAK2 inhibitor","Oncology","Myelofibrosis","myelofibrosis","MONDO_0044903",2022,TRUE,TRUE,"Pacritinib","CHEMBL2035187","ENSG00000096968, ENSG00000122025"
"Voquezna Triple Pak","Vonoprazan; amoxicillin; clarithromycin","Phathom","Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial","Other","Helicobacter pylori infection","Helicobacter pylori infectious disease","EFO_1000961",2022,NA,FALSE,"Vonoprazan; amoxicillin; clarithromycin","CHEMBL2079130; CHEMBL1082; CHEMBL1741","ENSG00000186009, ENSG00000105675; NA; NA"
"Vosevi","Sofosbuvir; velpatasvir; voxilaprevir","Gilead Sciences","Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor","Other","HCV","hepatitis C virus infection","EFO_0003047",2017,NA,NA,"SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR","CHEMBL1259059; CHEMBL3545062; CHEMBL3707372","NA; NA; NA"
"Voxzogo","Vosoritide","Biomarin","CNP analogue","Other","Achondroplasia","achondroplasia","MONDO_0007037",2021,TRUE,TRUE,"Vosoritide","CHEMBL3707276","ENSG00000159899"
"Vraylar","Cariprazine","Forest","Atypical antipsychotic","Other","Schizophrenia and bipolar 1 disorder","Schizophrenia; bipolar disorder","MONDO_0005090; MONDO_0004985",2015,TRUE,TRUE,"CARIPRAZINE","CHEMBL2028019","ENSG00000151577, ENSG00000149295"
"Vtama","Tapinarof","Dermavant","Aryl hydrocarbon receptor agonist","Other","Plaque psoriasis","psoriasis vulgaris","EFO_1001494",2022,TRUE,TRUE,"Tapinarof","CHEMBL259571","ENSG00000106546"
"Vyepti","Eptinezumab","Lundbeck","CGRP-directed mAb","Other","Migraine","migraine disorder","MONDO_0005277",2020,TRUE,TRUE,"EPTINEZUMAB","CHEMBL3833320","ENSG00000110680, ENSG00000175868"
"Vyleesi","Bremelanotide","Amag","Melanocortin receptor agonist","Other","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714",2019,TRUE,TRUE,"BREMELANOTIDE","CHEMBL2070241","ENSG00000166603"
"Vyndaqel","Tafamidis","Pfizer/Foldrx","Transthyretin stabilizer","Other","Heart disease caused by ATTR-CM","cardiomyopathy","EFO_0000318",2019,TRUE,TRUE,"TAFAMIDIS","CHEMBL2103837","ENSG00000118271"
"Vyondys 53","Golodirsen","Sarepta","Exon 53 skipping antisense","Other","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679",2019,TRUE,TRUE,"GOLODIRSEN","CHEMBL4297762","ENSG00000198947"
"Vyvgart","Efgartigimod alfa","Argenx","FcRn-binding Fc fragment","Other","Myasthenia gravis",NA,"EFO_0004991",2021,FALSE,FALSE,"Efgartigimod alfa","CHEMBL4297551","ENSG00000104870"
"Vyzulta","Latanoprostene bunod","Bausch and Lomb/Valeant Pharmaceuticals","Prostaglandin analogue","Other","Intraocular pressure","intraocular pressure measurement","EFO_0004695",2017,FALSE,FALSE,"LATANOPROSTENE BUNOD","CHEMBL2364612","ENSG00000122420"
"Wakix","Pitolisant","Harmony","H3-receptor antagonist/inverse agonist","Other","Excessive sleepiness due to narcolepsy","narcolepsy","MONDO_0021107",2019,FALSE,FALSE,"PITOLISANT","CHEMBL462605","ENSG00000101180"
"Welireg","Belzutifan","Merck & Co.","HIF-2alpha inhibitor","Oncology","von Hippel-Lindau disease","von Hippel-Lindau disease","MONDO_0008667",2021,TRUE,TRUE,"Belzutifan","CHEMBL4585668","ENSG00000116016"
"Winlevi","Clascoterone","Cassiopea SpA","Androgen receptor inhibitor","Other","Acne vulgaris","acne","EFO_0003894",2020,TRUE,TRUE,"CLASCOTERONE","CHEMBL3590187","ENSG00000169083"
"Xadago","Safinamide","US WorldMeds","MAO-B inhibitor","Other","Parkinson disease","Parkinson disease","MONDO_0005180",2017,TRUE,TRUE,"SAFINAMIDE","CHEMBL396778","ENSG00000069535"
"Xcopri","Cenobamate","SK Life Science","Unknown","Other","Partial onset seizures","seizure","HP_0001250",2019,TRUE,TRUE,"CENOBAMATE","CHEMBL3989949","ENSG00000168356, ENSG00000196876, ENSG00000185313, ENSG00000144285, ENSG00000153253, ENSG00000183873, ENSG00000136531, ENSG00000169432, ENSG00000136546, ENSG00000007314, ENSG00000186297, ENSG00000151834, ENSG00000011677, ENSG00000187730, ENSG00000109158, ENSG00000022355, ENSG00000166206, ENSG00000182256, ENSG00000145864, ENSG00000268089, ENSG00000145863, ENSG00000094755, ENSG00000163288, ENSG00000113327, ENSG00000102287, ENSG00000163285"
"Xeglyze","Abametapir","Dr Reddy‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨‚Ä¢s","Metalloproteinase inhibitor","Other","Head lice","lice infestation","MONDO_0003472",2020,NA,NA,"ABAMETAPIR","CHEMBL2205807","NA"
"Xenleta","Lefamulin","Nabriva","Pleuromutilin antibacterial","Other","CABP","bacterial pneumonia","EFO_1001272",2019,NA,NA,"LEFAMULIN","CHEMBL3291398","NA"
"Xenoview","Xenon Xe 129 hyperpolarized","Polarean","Hyperpolarized contrast agent","Other","MRI-evaluation of lung ventilation",NA,NA,2022,NA,NA,"Xenon Xe 129 hyperpolarized","CHEMBL4594411","NA"
"Xenpozyme","Olipudase alfa","Sanofi/Genzyme","Acid sphingomyelinase ERT","Other","Acid sphingomyelinase deficiency","acid sphingomyelinase deficiency","MONDO_0100464",2022,TRUE,TRUE,"Olipudase alfa","CHEMBL3707358","ENSG00000166311"
"Xepi","Ozenoxacin","Ferrer Internacional","Quinolone antimicrobial","Other","Impetigo due to Staphylococcus aureus or Streptococcus pyogenes","impetigo","EFO_1000714",2017,NA,NA,"OZENOXACIN","CHEMBL3990047","NA"
"Xerava","Eravacycline","Tetraphase Pharmaceuticals","Tetracycline antibiotic","Other","Complicated intra-abdominal infections","infectious disease","EFO_0005741",2018,NA,NA,"ERAVACYCLINE","CHEMBL1951095","NA"
"Xermelo","Telotristat etiprate","Lexicon Pharmaceuticals","Tryptophan hydroxylase inhibitor","Other","Carcinoid syndrome diarrhoea","carcinoid syndrome; Diarrhea","EFO_1000852; HP_0002014",2017,FALSE,FALSE,"TELOTRISTAT ETIPRATE","CHEMBL3348963","ENSG00000129167, ENSG00000139287"
"Xiidra","Lifitegrast","Shire Pharmaceuticals","LFA1 antagonist","Other","Dry eye disease","dry eye syndrome","EFO_1000906",2016,FALSE,FALSE,"LIFITEGRAST","CHEMBL2048028","ENSG00000160255, ENSG00000005844"
"Xofigo","Radium RA 223 dichloride","Bayer","Alpha particle-emitting radioactive therapeutic","Other","Castration-resistant prostate cancer","prostate cancer","MONDO_0008315",2013,NA,NA,"RADIUM RA 223 DICHLORIDE","CHEMBL2107816","NA"
"Xofluza","Baloxavir marboxil","Shionogi/Roche","Polymerase acidic endonuclease inhibitor","Other","Acute uncomplicated influenza","influenza","EFO_0007328",2018,NA,NA,"BALOXAVIR MARBOXIL","CHEMBL4297503","NA"
"Xospata","Gilteritinib","Astellas","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia","EFO_0000222",2018,TRUE,TRUE,"GILTERITINIB","CHEMBL3301622","ENSG00000122025, ENSG00000167601"
"Xpovio","Selinexor","Karyopharm Therapeutics","XPO1 inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378",2019,TRUE,TRUE,"SELINEXOR","CHEMBL3545185","ENSG00000082898"
"Xtoro","Finafloxacin","Alcon","Fluoroquinolone antimicrobial","Other","Acute otitis externa (swimmer's ear)","otitis externa","EFO_0009560",2014,NA,NA,"FINAFLOXACIN","CHEMBL1908370","NA"
"Xuriden","Uridine","Wellstat","Pyrimidine analogue","Other","Hereditary orotic aciduria","Hereditary orotic aciduria","Orphanet_30",2015,NA,NA,"URIDINE","CHEMBL100259","NA"
"Yondelis","Trabectedin","Johnson & Johnson","Alkylating drug","Oncology","Liposarcoma or leiomyosarcoma","liposarcoma; leiomyosarcoma","EFO_0000569; EFO_0000564",2015,NA,NA,"TRABECTEDIN","CHEMBL450449","NA"
"Yupelri","Revefenacin","Theravance Biopharma/Mylan","Long-acting muscarinic receptor antagonist","Other","COPD","chronic obstructive pulmonary disease","EFO_0000341",2018,TRUE,TRUE,"REVEFENACIN","CHEMBL3833319","ENSG00000133019"
"Zegalogue","Dasiglucagon","Zealand Pharma","Glucagon receptor agonist","Other","Severe hypoglycaemia","GCGR-related hyperglucagonemia","EFO_0001360",2021,FALSE,FALSE,"Dasiglucagon","CHEMBL4297741","ENSG00000215644"
"Zejula","Niraparib","Tesaro","PARP inhibitor","Oncology","Epithelial ovarian, fallopian tube or primary peritoneal cancer","fallopian tube cancer; ovarian epithelial tumor; primary peritoneal carcinoma","MONDO_0002158; MONDO_0002229; MONDO_0015686",2017,TRUE,TRUE,"NIRAPARIB","CHEMBL1094636","ENSG00000129484, ENSG00000143799"
"Zemdri","Plazomicin","Achaogen","Aminoglycoside antibacterial","Other","Urinary tract infections","urinary tract infection","EFO_0003103",2018,NA,NA,"PLAZOMICIN","CHEMBL1650559","NA"
"Zepatier","Elbasvir; grazoprevir","Merck & Co.","NS5A inhibitor plus NS3/4A protease inhibitor","Other","HCV genotypes 1 and 4","hepatitis C virus infection","EFO_0003047",2016,NA,NA,"ELBASVIR; GRAZOPREVIR","CHEMBL3039514; CHEMBL2063090","NA; NA"
"Zeposia","Ozanimod","Celgene/Bristol Myers Squibb","S1P receptor modulator","Other","Multiple sclerosis","multiple sclerosis","MONDO_0005301",2020,TRUE,TRUE,"OZANIMOD","CHEMBL3707247","ENSG00000170989"
"Zepzelca","Lurbinectedin","Jazz","Alkylating drug","Oncology","Small-cell lung cancer","small cell lung carcinoma","EFO_0000702",2020,NA,NA,"LURBINECTEDIN","CHEMBL4297516","NA"
"Zerbaxa","Ceftolozane; tazobactam","Cubist","A cephalosporin antibacterial plus a beta-lactamase inhibitor","Other","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544",2014,NA,NA,"CEFTOLOZANE; TAZOBACTAM","CHEMBL2103872; CHEMBL404","NA; NA"
"Zinbryta","Daclizumab","Biogen","IL-2-targeted mAb","Other","Multiple sclerosis","multiple sclerosis","MONDO_0005301",2016,TRUE,TRUE,"DACLIZUMAB","CHEMBL1201605","ENSG00000134460, ENSG00000100385, ENSG00000147168"
"Zinplava","Bezlotoxumab","Merck & Co.","mAb against Clostridium difficile toxin","Other","C. difficile recurrence","clostridium difficile infection","EFO_0009130",2016,NA,NA,"BEZLOTOXUMAB","CHEMBL2108670","NA"
"Zokinvy","Lonafarnib","Eiger","Farnesyltransferase inhibitor","Other","HGPS","hutchinson-gilford progeria syndrome","MONDO_0008310",2020,FALSE,FALSE,"LONAFARNIB","CHEMBL298734","ENSG00000257365, ENSG00000168522"
"Zontivity","Vorapaxar","Merck & Co.","Protease-activated receptor 1 antagonist","Other","Thrombotic cardiovascular events (after myocardial infarction or with peripheral arterial disease*)","myocardial infarction; peripheral arterial disease","EFO_0000612; EFO_0004265",2014,FALSE,FALSE,"VORAPAXAR","CHEMBL493982","ENSG00000181104"
"Ztalmy","Ganaxolone","Marinus","GABAA receptor positive allosteric modulator","Other","Seizures associated with CDD","Epileptic encephalopathy","HP_0200134",2022,TRUE,TRUE,"Ganaxolone","CHEMBL1568698","ENSG00000094755, ENSG00000163288, ENSG00000102287, ENSG00000166206, ENSG00000145863, ENSG00000022355, ENSG00000113327, ENSG00000187730, ENSG00000011677, ENSG00000268089, ENSG00000145864, ENSG00000151834, ENSG00000186297, ENSG00000182256, ENSG00000109158, ENSG00000163285"
"Zulresso","Brexanolone","Sage Therapeutics","GABAA-receptor-positive modulator","Other","Postpartum depression","postpartum depression","EFO_0007453",2019,TRUE,TRUE,"BREXANOLONE","CHEMBL207538","ENSG00000094755, ENSG00000109158, ENSG00000186297, ENSG00000022355, ENSG00000145864, ENSG00000166206, ENSG00000182256, ENSG00000011677, ENSG00000268089, ENSG00000102287, ENSG00000113327, ENSG00000163285, ENSG00000151834, ENSG00000145863, ENSG00000163288, ENSG00000187730"
"Zurampic","Lesinurad","AstraZeneca","URAT1 inhibitor","Other","Gout","gout","EFO_0004274",2015,TRUE,TRUE,"LESINURAD","CHEMBL2105720","ENSG00000197891"
"Zydelig","Idelalisib","Gilead Sciences","PI3K‚p110-delta subunit inhibitor","Other","CLL, B-cell non-Hodgkin lymphoma and SLL","chronic lymphocytic leukemia; B-cell non-Hodgkins lymphoma","EFO_0000095; EFO_1001938",2014,TRUE,TRUE,"IDELALISIB","CHEMBL2216870","ENSG00000171608"
"Zykadia","Ceritinib","Novartis","Kinase inhibitor against ALK, IGF1R, insulin receptor and ROS1","Oncology","ALK-positive metastatic NSCLC","non-small cell lung carcinoma","EFO_0003060",2014,TRUE,TRUE,"CERITINIB","CHEMBL2403108","ENSG00000171094, ENSG00000143924, ENSG00000181163"
"Zynlonta","Loncastuximab tesirine","ADC Therapeutics","CD19-targeted ADC","Oncology","B-cell lymphoma","B-cell non-Hodgkins lymphoma","EFO_1001938",2021,TRUE,TRUE,"Loncastuximab tesirine","CHEMBL4297778","ENSG00000177455"
